Conference Agenda

Initiation of mitochondrial DNA replication in mammalian cells.

Maria Falkenberg

Gothenburg University, Sweden

Regulation of mitochondrial gene expression in disease

Aleksandra Filipovska

University of Western Australia, Australia

Mitochondrial translation termination at non-canonical stop codons

Annika Krüger¹, Cristina Remes², Dmitrii Igorevich Shiriaev¹, Yong Liu¹, Henrik Spåhr¹, Rolf Wibom¹, Ilian Atanassov³, Minh Duc Nguyen¹, Barry S. Cooperman², Joanna Rorbach^1,3

1: Karolinska Institutet, Stockholm, Sweden; 2: University of Pennsylvania, Pennsylvania, USA; 3: Max-Planck-Institute for Biology of Ageing, Cologne, Germany

Pathological variants in TOP3A cause distinct disorders of mitochondrial and nuclear genome stability

Direnis Erdinc¹, Alejandro Rodríguez-Luis^2,3, Mahmoud R. Fassad^2,4, Sarah Mackenzie⁵, Christopher M. Watson^6,7, Sebastian Valenzuela¹, Xie Xie¹, Katja E. Menger^2,3, Kate Sergeant⁸, Kate Craig^2,9, Sila Hopton^2,9, Gavin Falkous^2,9, Joanna Poulton¹⁰, Hector Garcia-Moreno¹¹, Paola Giunti¹¹, Carlos A. de Moura Aschoff¹², Jonas A. Morales Saute^12,13,14, Amelia J. Kirby¹⁵, Camilo Toro¹⁶, Lynne Wolfe¹⁶, Danica Novacic¹⁶, Lior Greenbaum^17,18,19, Aviva Eliyahu^17,19, Ortal Barel²⁰, Yair Anikster^19,21, Robert McFarland^2,4, Gráinne S. Gorman^2,4, Andrew M. Schaefer^2,9, Claes M. Gustafsson^1,22, Robert W. Taylor^2,4,9, Maria Falkenberg¹, Thomas J Nicholls¹

1: Department of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, SE-405 30 Gothenburg, Sweden; 2: Wellcome Centre for Mitochondrial Research, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK; 3: Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK; 4: Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK; 5: The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK; 6: North East and Yorkshire Genomic Laboratory Hub, Central Lab, St. James's University Hospital, Leeds, UK; 7: Leeds Institute of Medical Research, University of Leeds, St. James's University Hospital, Leeds, UK; 8: Oxford Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; 9: NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE1 4LP, UK; 10: Nuffield Department of Women’s & Reproductive Health, The Women's Centre, University of Oxford, Oxford, UK; 11: Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK; 12: Medical Genetics Service, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil; 13: Department of Internal Medicine, Universidade Federal do Rio Grande do Sul - Porto Alegre, Brazil; 14: Graduate Program in Medicine: Medical Sciences, Universidade Federal do Rio Grande do Sul - Porto Alegre, Brazil; 15: Department of Pediatrics, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA; 16: Undiagnosed Diseases Program, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA; 17: The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Tel Hashomer, Israel; 18: The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel; 19: The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; 20: Genomics Unit, The Center for Cancer Research, Sheba Medical Center, Israel; 21: Metabolic Disease Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel; 22: Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden

The role of replicative exonucleases in mitochondrial DNA replication and degradation

Christian D Gonzalez, Nadee Nissanka, Carlos T Moraes

University of Miami Miller School of Medicine, United States of America

Processing of mitochondrial RNA in health and disease: the role of FASTKD5.

Hana Antonicka¹, James B. Gibson², Eric A. Shoubridge¹

1: The Neuro & McGill University, Montreal, Quebec, Canada; 2: Dell School of Medicine, University of Texas at Austin, Austin, TX, USA

Mechanisms of mtDNA maintenance and segregation in the female germline

Laura Kremer¹, Lyuba Bozhilova^2,3, Diana Rubalcava-Garcia¹, Roberta Filograna¹, Mamta Upadhyay¹, Camilla Koolmeister¹, Patrick Chinnery^2,3, Nils-Göran Larsson¹

1: Karolinska Institutet, Stockholm, Sweden; 2: MRC Mitochondrial Biology Unit, Cambridge, United Kingdom; 3: Department of Clinical Neurosciences, University of Cambridge, United Kingdom

The human Mitochondrial mRNA Structurome reveals Mechanisms of Gene Expression in Physiology and Pathology

Antoni Barrientos¹, Conor Moran¹, Amir Brivanlou², Flavia Fontanesi¹, Silvi Rouskin²

1: University of Miami, United States of America; 2: Harvard Medical School, United States of America

The role of mitochondria in neuromuscular diseases

Rita Horvath

Cambridge-UK, United Kingdom

Innovative approaches for the molecular diagnosis of mitochondrial disorders

Holger Prokisch

Technical University Munich Institute of Human Genetics

Specialist multidisciplinary input maximises rare disease diagnoses from whole genome sequencing

William L Macken^1,2, Micol Falabella¹, Caroline McKittrick¹, Chiara Pizzamiglio^1,2, Rebecca Ellmers³, Kelly Eggleton³, Cathy E. Woodward^2,3, Yogen Patel^2,3, Robyn Labrum^2,3, Genomics England Research Consortium⁹, Rahul Phadke⁴, Mary M. Reilly¹, Catherine DeVille⁵, Anna Sarkozy⁴, Emma Footitt⁶, James Davison^6,7, Shamima Rahman^6,8, Henry Houlden¹, Enrico Bugiardini^1,2, Rosaline Quinlivan^1,2,4, Michael G. Hanna^1,2, Jana Vandrovcova¹, Robert D.S. Pitceathly^1,2

1: Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK; 2: NHS Highly Specialised Service for Rare Mitochondrial Disorders, Queen Square Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, London, UK; 3: Neurogenetics Unit, Rare and Inherited Disease Laboratory, North Thames Genomic Laboratory Hub, London, UK; 4: Dubowitz Neuromuscular Centre, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK; 5: Department of Neurosciences, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK; 6: Metabolic Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK; 7: National Institute for Health and Care Research Great Ormond Street Hospital Biomedical Research Centre, London, UK; 8: Mitochondrial Research Group, UCL Great Ormond Street Institute of Child Health, London, UK; 9: Genomics England, One Canada Square London, UK

Biallelic variants in MCAT in an infant with lactic acidosis, lipoylation disorder, and early death

Melanie T. Achleitner¹, Maja Hempel^2,3, Konstantinos Tsiakas⁴, René G. Feichtinger¹, Saskia B. Wortmann^1,5, René Santer⁴, Johannes A. Mayr¹

1: University Children's Hospital, Paracelsus Medical University, Salzburg, Austria; 2: Institute of Human Genetics, University Medical Center Eppendorf, Hamburg, Germany; 3: Current address: Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany; 4: Department of Pediatrics, University Medical Center Eppendorf, Hamburg, Germany; 5: Amalia Children’s Hospital, Radboudumc, Nijmegen, The Netherlands.

Biallelic PTPMT1 variants impair cardiolipin metabolism and cause mitochondrial myopathy and developmental regression

Micol Falabella¹, Chiara Pizzamiglio^1,2, Luis Carlos Tabara³, Ece Sonmezler⁴, Benjamin Munro⁵, William L. Macken^1,2, Shanti Lu¹, Lisa Tilokani³, Padraig J. Flannery^6,7, Nina Patel^7,8, Simon A. S. Pope^7,8, Simon J. R. Heales^7,8, Jana Vandrovcova¹, Henry Houlden¹, Robert W. Taylor⁹, Cathy E. Woodward⁶, Robyn Labrum⁶, Genomics England Research Consortium¹⁰, Semra Hiz¹¹, Maha S. Zaki¹², Efstathia Chronopoulou¹³, Germaine Pierre¹³, Reza Maroofian¹, Michael G. Hanna^1,2, Yavuz Oktay^4,14,15, Rita Horvath⁵, Julien Prudent³, Robert D. S. Pitceathly^1,2

1: Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK; 2: NHS Highly Specialised Service for Rare Mitochondrial Disorders, Queen Square Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, London, UK; 3: Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge UK; 4: Izmir International Biomedicine and Genome Institute, Dokuz Eylül University, Izmir, Turkey; 5: Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK; 6: Neurogenetics Unit, Rare and Inherited Disease Laboratory, North Thames Genomic Laboratory Hub, London, UK; 7: Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, UK; 8: Neurometabolic Unit, The National Hospital for Neurology and Neurosurgery, London, UK; 9: Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children, Newcastle University, Newcastle upon Tyne, UK; 10: Genomics England, London, UK; 11: Izmir Biomedicine and Genome Center, Dokuz Eylul University Health Campus, Izmir, Turkey; 12: Clinical Genetics Department, Human Genetics and Genome Research Division, National Research Centre, Cairo, Egypt; 13: Department of Inherited Metabolic Disease, Division of Women's and Children's Services, University Hospitals Bristol NHS Foundation Trust, Bristol, UK; 14: Izmir Biomedicine and Genome Center, Izmir, Turkey; 15: Department of Medical Biology, Faculty of Medicine, Dokuz Eylül University, Izmir Turkey

Heterozygous missense variants in NUTF2 (nuclear transport factor 2) gene, mapping at the OPA8 locus, cause Dominant Optic Atrophy

Agnese Macaluso¹, Alessandra Maresca¹, Concetta Valentina Tropeano¹, Maria Antonietta Capristo¹, Flavia Palombo¹, Leonardo Caporali¹, Claudio Fiorini¹, Danara Ormanbekova¹, Chiara La Morgia¹, Piero Barboni^2,3, Cristina Villaverde^4,5, Carmen Ayuso^4,5, Maria Esther Gallardo^6,5, Majida Charif⁷, Sylvie Gerber⁸, Patrizia Amati-Bonneau⁷, Guy Lanaers^7,9, Jean-Michel Rozet⁷, Bernd Wissinger¹⁰, Valerio Carelli^1,11, Valentina Del Dotto¹¹

1: IRCCS - Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica - Bologna (Italy); 2: Studio Oculistico d'Azeglio - Bologna (Italy); 3: Department of Ophthalmology, University Vita-Salute, IRCCS Ospedale San Raffaele - Milano (Italy); 4: Department of Genetics & Genomics, Instituto de Investigación Sanitaria - Fundación Jiménez Díaz University Hospital - Universidad Autónoma de Madrid (IIS-FJD-UAM) - Madrid (Spain); 5: Center for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII - Madrid (Spain); 6: Grupo de investigación traslacional con células iPS, Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12), Madrid, Spain; Centro de Investigación Biomédica en Red (CIBERER) - Madrid (Spain); 7: Université d’Angers, MitoLab team, UMR CNRS 6015 - INSERM U1083, Unité MitoVasc - Angers (France); 8: Laboratory of Genetics in Ophthalmology (LGO), INSERM UMR1163, Institute of Genetic Diseases, Imagine and Paris Descartes University - Paris (France); 9: Departments of Biochemistry and Genetics, University Hospital Angers - Angers (France); 10: Molecular Genetics Laboratory, Institute for Ophthalmic Research, Center for Ophthalmology, University of Tübingen, Tübingen, Germany; 11: Depart. of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna - Bologna (Italy)

Southern African paediatric patients with King Denborough syndrome are exclusively associated with an autosomal recessive STAC3 variant: is this a highly prevalent secondary mitochondrial disease in this African population?

Francois Hendrikus van der Westhuizen¹, Maryke Schoonen¹, Michelle Bisschoff¹, Ronel Human², Elsa Lubbe², Malebo Nonyane², Armand Vorster¹, Karin Terburgh¹, Robert McFarland³, Robert Taylor³, Mahmoud Fassad³, Krutik Patel³, Wilson Lindsay⁴, Michael Hanna⁴, Jana Vandrovcova⁴, The ICGNMD Consortium⁵, Izelle Smuts²

1: Human Metabolomics, North-West University, Potchefstroom, South Africa; 2: Department of Paediatrics, Steve Biko Academic Hospital, University of Pretoria, Pretoria, South Africa; 3: Wellcome Centre for Mitochondrial Research, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom; 4: Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United Kingdom; 5: https://www.ucl.ac.uk/genomic-medicine-neuromuscular-diseases/global-contributor-list

AK3, adenylate kinase isozyme 3, is a new gene associated with PEO and multiple mtDNA deletions

Alessia Nasca¹, Andrea Legati¹, Teresa Ciavattini¹, Nadia Zanetti¹, Eleonora Lamantea¹, Javier Ramón², Ramon Martí², Maria Antonietta Maioli³, Costanza Lamperti¹, Holger Prokisch^4,5, Daniele Ghezzi^1,6

1: Fondazione IRCCS Istituto Neurologico Besta, Italy; 2: Vall d'Hebron Research Institute, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Autonomous University of Barcelona, Barcelona, Spain; 3: Centro Sclerosi Multipla, P.O. Binaghi, ASL Cagliari, Italy; 4: Technical University of Munich, School of Medicine, Institute of Human Genetics, 81675 Munich, Germany; 5: Institute of Neurogenomics, Helmholtz Zentrum München, 85764 Munich, Germany; 6: Department of Pathophysiology and Transplantation (DEPT), University of Milan, Italy

Guanylate kinase 1 deficiency: a novel and potentially treatable form of mitochondrial DNA depletion/deletions syndrome

Agustin Hidalgo-Gutierrez¹, Jonathan Shintaku¹, Eliana Barriocanal-Casado¹, Russ Saneto², Javier Ramon^4,7, Gloria Garrabou^4,5, Frederic Tort^3,4, Jose Cesar Milisenda⁶, Laura Gort^3,4, Alba Pesini¹, Saba Tadesse¹, Mary-Claire King⁸, Ramon Marti^4,7, Antonia Ribes^3,4, Michio Hirano¹

1: Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA; 2: Seattle Children’s Hospital, Seattle, WA, USA; 3: Section of Inborn Errors of Metabolism-IBC. Department of Biochemistry and Molecular Genetics. Hospital Clinic de Barcelona-IDIBAPS, Barcelona.; 4: Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Barcelona; 5: Muscle Research and Mitochondrial Function Lab, Cellex - IDIBAPS. Faculty of Medicine and Health Science - University of Barcelona (UB), Barcelona.; 6: Department of Internal Medicine, Hospital Clínic of Barcelona.; 7: Vall d’Hebron Research Institute, Autonomous University of Barcelona, Barcelona, Spain.; 8: Department of Genome Sciences, University of Washington, Seattle, WA, U.S.A.

Metabolic adaptations of respiratory chain organization and function

Erika Fernandez-Vizarra^1,2

1: Department of Biomedical Sciences, University of Padova, Italy; 2: Veneto Institute of Molecular Medicine, Padova, Italy

Pluripotent stem cells and brain organoids for drug discovery of mitochondrial diseases

Alessandro Prigione

Heinrich Heine University, Düsseldorf, Germany

High-throughput single cell analysis reveals progressive mitochondrial DNA mosaicism developing throughout life

Angelos Glynos^1,2, Lyuba V. Bozhilova^1,2, Michele Frison^1,2, Stephen P. Burr^1,2, James B. Stewart³, Patrick F. Chinnery^1,2

1: Department of Clinical Neurosciences, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK; 2: Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK; 3: Biosciences Institute, Faculty of Medical Sciences, Wellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK

A coordinated multiorgan metabolic response contributes to human mitochondrial myopathy.

Guido Primiano³, Nneka Southwell¹, Viraj Nadkarni¹, Emelie Beattie¹, Maria Lucia Valentino⁴, Valerio Carelli⁴, Serenella Servidei³, Giovanni Manfredi¹, Qiuying Chen², Marilena D'Aurelio¹

1: Weill Cornell Medicine, Brain and Mind Research Institute, New York, NY; 2: Weill Cornell Medicine, Department of Pharmacology, New York, NY; 3: Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy; Dipartimento di Neuroscienze, Università Cattolica del Sacro Cuore, Rome, Italy; 4: IRCCS, Institute of Neurological Sciences of Bologna, Bellaria Hospital, Bologna, Italy; Department of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, Bologna, Italy

Succinylation as a novel pathogenic mechanism in a children's mitochondrial brain disease

Pieti Elonkirjo¹, Tuomas Kukkonen¹, Juan Liu², Jason W. Locasale², Sami Jalil¹, Birgit Schilling³, Eric Verdin^3,4, Marco Reidelbach⁵, Outi Haapanen⁵, Vivek Sharma^5,6, Elsebet Oestergaard⁷, Rosalba Carrozzo⁸, Berge Minassian^9,10, Anu Suomalainen¹

1: STEMM, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland; 2: Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA; 3: Buck Institute for Research on Aging, Novato, CA 94945, USA; 4: Gladstone Institutes and University of California, San Francisco, CA 94158, USA; 5: Department of Physics, University of Helsinki, Finland; 6: HiLIFE Institute of Biotechnology, University of Helsinki, Finland; 7: Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, 2100 Copenhagen, Denmark; 8: Unit of Cellular Biology and Mitochondrial Diseases, “Bambino Gesù” Children's Hospital, IRCCS, Rome, Italy; 9: Program in Genetics and Genome Biology, The Hospital for Sick Children, Institute of Medical Science University of Toronto, Toronto, Ontario, Canada; 10: Division of Neurology, Department of Pediatrics, University of Texas Southwestern, Dallas, TX, USA

The levels and activation state of the pyruvate dehydrogenase complex modulate the SCAFI-dependent organization of the mitochondrial respiratory chain

Sandra Lopez-Calcerrada¹, Ana Sierra-Magro¹, Erika Fernández-Vizarra², Cristina Ugalde^1,3

1: Instituto de Investigación Hospital 12 de Octubre, Madrid 28041, Spain; 2: Department of Biomedical Sciences, University of Padova, 35131 Padova, Italy; 3: Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), U723, Madrid, Spain

Oxphos deficiency indicates novel functions for the mitochondrial protein import subunit tim50

Jordan J Crameri¹, Catherine S Palmer¹, David Coman², David A Stroud¹, David R Thorburn^3,4,5, Ann E Frazier^3,4, Diana Stojanovski¹

1: Department of Biochemistry and Pharmacology and the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, 3010, Australia; 2: Queensland Children’s Hospital, Department of Metabolic Medicine, South Brisbane, Brisbane, Queensland, 4001, Australia; 3: Murdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne, Victoria, 3052, Australia; 4: Department of Paediatrics, University of Melbourne, Melbourne, Victoria, 3052, Australia; 5: Victorian Clinical Genetics Services, Royal Children’s Hospital, Melbourne, Victoria, 3052, Australia

Microproteins in metabolic regulation

Jiemin Nah¹, Baptiste Kerouanton¹, David Robinson², Kyle Dunlap³, Pooja Sridnivasan¹, Sonia Chothani¹, Greg Ducker³, Owen Rackham⁴, David Stroud², Lena Ho¹

1: Duke-NUS Medical School, Singapore; 2: University of Melbourne, Australia; 3: University of Utah, USA; 4: University of Southampton, UK

Recessive MECR pathogenic variants cause a LHON-like optic neuropathy

Claudio Fiorini¹, Andrea Degiorgi², Maria Lucia Cascavilla³, Concetta Valentina Tropeano¹, Chiara La Morgia^1,4, Marco Battista³, Danara Ormanbekova¹, Flavia Palombo¹, Michele Carbonelli⁴, Francesco Bandello³, Valerio Carelli^1,4, Alessandra Maresca¹, Piero Barboni³, Enrico Baruffini², Leonardo Caporali⁴

1: IRCCS Istituto delle Scienze Neurologiche di Bologna, Italy; 2: Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy; 3: Department of Ophthalmology, University Vita-Salute, IRCCS Ospedale San Raffaele, Milan, Italy; 4: Department of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, Italy

Variants in ATP5F1B are associated with dominantly inherited dystonia

Alessia Nasca¹, Niccolò Mencacci², Federica Invernizzi¹, Michael Zech³, Andrea Legati¹, Giovanna Zorzi¹, Holger Prokisch³, Steven Lubbe², Barbara Garavaglia¹, Daniele Ghezzi^1,4

1: Fondazione IRCCS Istituto Neurologico Besta, Milan, Italy; 2: Northwestern University, Feinberg School of Medicine, Chicago, USA; 3: Helmholtz Zentrum München, Technical University of Munich, Munich, Germany; 4: Università di Milano, Milan, Italy

Toward clinical implementation of quantitative proteomics in the detection of mitochondrial disorders

Daniella H Hock¹, Liana N Semcesen¹, Nikeisha J Caruana^1,2, Sumudu Amarasekera^1,3, Teresa Zhao^1,3,4, Ann E Frazier^1,3, Shabnam Bakhshalizadeh^1,3, Megan Ball^1,3,4, Tegan Stait^3,4, Jessie Jacobsen^5,6, Emma Glamuzina^5,6, Bryony Ryder^5,6, Johan L K Van Hove⁷, Elena Tucker^1,3, Andrew Sinclair^1,3,4, Cas Simons^8,9, Alison G Compton^1,3,4, John Christodoulou^1,3,4, David R Thorburn^1,3,4, David A Stroud^1,3,4

1: University of Melbourne, Parkville, Australia; 2: Victoria University, Footscray, Australia; 3: Murdoch Children’s Research Institute, Melbourne, Australia; 4: Victorian Clinical Genetics Services, Melbourne, Australia; 5: National Metabolic Service Auckland City Hospital, Auckland, New Zealand; 6: Starship Children's Hospital, Auckland, New Zealand; 7: University of Colorado, Aurora, United States of America; 8: Centre for Population Genomics, Melbourne, Australia; 9: Garvan Institute of Medical Research, Sydney, Australia

A DNM2-related myopathy mimicking a primary mitochondrial disorder

Ignazio Giuseppe Arena¹, Rosalba Carrozzo², Mattia Porcino¹, Alba Migliorato³, Carmelo Rodolico¹, Olimpia Musumeci¹

1: Unit of Neurology and Neuromuscular Disorders, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.; 2: Department of Neurosciences, Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy; 3: Unit of Neurology and Neuromuscular Disorders, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Assessing the association of mitochondrial DNA genes with Primary Mitochondrial Disease using the ClinGen Clinical Validity Framework

Elizabeth M. McCormick¹, James T. Peterson¹, Julie P. Taylor², Krista Bluske², Amanda R. Clause², Anjana Chandrasekhar², Josh Lowry², Alison J. Coffey², Xiaowu Gai^3,4, Marni J. Falk^1,5, Zarazuela Zolkipli-Cunningham^1,5, Shamima Rahman⁶

1: Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA; 2: Illumina Laboratory Services, Illumina Inc., San Diego, CA; 3: Center for Personalized Medicine, Department of Pathology & Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA; 4: Keck School of Medicine, University of Southern California, Los Angeles, CA; 5: Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; 6: Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, United Kingdom

Functional characterisation of the m.8424T>C MT-ATP8 variant using quantitative proteomics

Liana Semcesen¹, Nikeisha Caruana^1,2, Daniella Hock¹, Alison Compton^1,3,4, Zornitza Stark^1,4,5, John Christodoulou^1,3,4, David Thorburn^1,3,4, David Stoud^1,3,4

1: University of Melbourne, Parkville, Australia; 2: Victoria University, Footscray, Australia; 3: Murdoch Children’s Research Institute, Melbourne, Australia; 4: Victorian Clinical Genetics Services, Melbourne, Australia; 5: Australian Genomics, Melbourne, Australia

COX18 variants cause isolated Complex IV deficiency associated with neonatal hypertrophic cardiomyopathy, myopathy and axonal sensory neuropathy

Dario Ronchi¹, Megi Meneri^1,2, Francesca Magri², Francesca Menni², Manuela Garbellini², Maria Francesca Bedeschi², Robertino Dilena², Valeria Cecchetti², Irene Picciolli², Francesca Furlan², Valentina Polimeni², Sabrina Salani², Laura Pezzoli², Francesco Fortunato¹, Matteo Bellini³, Sara Antognozzi², Daniela Piga², Michela Ripolone², Simona Zanotti², Laura Napoli², Patrizia Ciscato², Monica Sciacco², Giovanna Mangili³, Fabio Mosca², Stefania Corti^1,2, Maria Iascone³, Giacomo Pietro Comi^1,2

1: Dino Ferrari Center, University of Milan, Italy; 2: IRCCS Cà Granda Ospedale Maggiore Policlinico Milan, Italy; 3: ASST Papa Giovanni XXIII, Bergamo, Italy

Severe mitochondrial encephalomyopathy caused by de novo variants in OPA1

Daria Diodato¹, Michela Di Nottia², Alessandra Torraco², Teresa Rizza², Claudia Nesti³, Enrico Baruffini³, Diego Martinelli⁴, Margherita Verardo¹, Adele D'Amico¹, Filippo Maria Santorelli⁵, Enrico Bertini¹, Rosalba Carrozzo²

1: Muscular and Neurodegenerative Disorders Unit, Children Hospital Bambino Gesù; 2: Cellular biology and mitochondrial diseases diagnostics, Children Hospital Bambino Gesù; 3: Department of Chemistry Life Sciences and Environmental Sustainability, University of Parma; 4: Metabolism Division, Children Hospital Bambino Gesù, Rome; 5: Molecular Medicine, IRCCS Stella Maris, Pisa

Bi-allelic TEFM variants are associated with a treatable mitochondrial myopathy

Alessandra Torraco¹, Guido Primiano^2,3, Anastasia Altobelli¹, Teresa Rizza¹, Michela Di Nottia¹, Rosalba Carrozzo¹, Serenella Servidei^2,3

1: Unit of Cellular Biology and Diagnosis of Mitochondrial Disease, Bambino Gesù Children’s Hospital, IRCCS, Rome Italy.; 2: Dipartimento di Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.; 3: Dipartimento Di Neuroscienze, Università Cattolica del Sacro Cuore, Rome, Italy.

TOMM40L as a new causative gene for autosomal recessive mitochondrial disease.

Francisco Javier Cotrina Vinagre¹, María Elena Rodríguez García¹, Lucía Del Pozo Filiú¹, Elena Martín Hernández^2,3, Francisco Martínez Azorín^1,3

1: Laboratorio de Enfermedades Mitocondriales. Instituto de Investigación Hospital 12 de Octubre (i+12), E-28041 Madrid, Spain.; 2: Unidad Pediátrica de Enfermedades Raras, Enfermedades Mitocondriales y Metabólicas Hereditarias, Hospital 12 de Octubre, E-28041, Madrid, Spain.; 3: Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), U723, E-28041 Madrid, Spain.

A primary cardiological phenotype caused by an inherited mtDNA single deletion: a case report from an Italian pedigree

Piervito Lopriore¹, Christiane Neuhofer^2,3, Vincenzo Montano¹, Adriana Meli¹, Annalisa Lo Gerfo⁴, Giulia Cecchi⁴, Maria Adelaide Caligo⁴, Riccardo Berutti^2,3, Robert Kopajtich^2,3, Gabriele Siciliano¹, Holger Prokisch^2,3, Michelangelo Mancuso¹

1: Department of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, Pisa, Italy; 2: Institute of Human Genetics, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany; 3: Institute of Neurogenomics, Computational Health Center, Helmholtz Zentrum München, Neuherberg, Germany; 4: Laboratory of Molecular Genetics, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy

Genetic characterization of a large cohort of Spanish patients with TK2 deficiency. A founder effect of two TK2 variants partially contributes to a higher prevalence of the disorder in Spain.

Cristina Domínguez-González^1,2, Pablo Serrano-Lorenzo^1,2, Alberto Blázquez^1,2, Juan Francisco Quesada-Espinosa¹, Jorge Amigo Lechuga³, Pablo Mínguez^2,4, Carmen Ayuso^2,4, Elena García-Arumí⁵, Nuria Muelas^2,6, Teresa Jaijo⁶, Andrés Nascimento⁷, Beatriz Galán-Rodriguez⁸, Carmen Paradas^8,9, Joaquín Arenas^1,2, Ángel Carracedo^2,3, Ramon Martí^2,5, Miguel A. Martin^1,2

1: Hospital Universitario 12 de Octubre, imas12 Research Institute, Madrid, Spain; 2: Spanish Network for Biomedical Research in Rare Diseases (CIBERER); 3: Fundación Galega de Medicina Xenómica, Santiago de Compostela, Spain; 4: Instituto de Investigación Sanitaria, Hospital Universitario FundaciónJiménez Díaz, Madrid, Spain; 5: Research Group on Neuromuscular and Mitochondrial Diseases, Vall d’Hebron Research Institute, Autonomous University of Barcelona, Barcelona; 6: Hospital Universitari I Politècnic La Fe, Neuromuscular and Ataxias Research Group, Instituto de Investigación Sanitaria La Fe, Valencia; 7: Sant Joan de Déu Research Institute, Sant Joan de Déu Hospital, Barcelona, Spain.; 8: Instituto de Biomedicina de Sevilla, Hospital U. Virgen del Rocío, Sevilla, Spain.; 9: Center for Biomedical Network Research on Neurodegenerative Disorders (CIBERNED)

HSD17B10 interacts with CBR4 to form human mitochondrial 3-ketoacyl-acyl carrier protein reductase 2 (KAR2) in the mitochondrial fatty acid synthesis pathway

Ali Julfiker Md Masud, Guangyu Jiang, Kaija J Autio, J Kalervo Hiltunen, Alexander J Kastaniotis

Faculty of Biochemistry and Molecular Medicine, University of Oulu, Finland

Novel atypical variants causing pyruvate dehydrogenase complex deficiency

Helene Bruhn^1,2, Karin Naess^1,2, Sofia Ygberg^2,3, Nicole Lesko^2,4, Rolf Wibom^1,2, Anna Wedell^2,4, Anna Wredenberg^1,2

1: Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden; 2: Centre of inherited metabolic diseases, Karolinska University Hospital, Stockholm, Sweden; 3: Neuropediatric Unit, Dept of Women’s, and Children's Health, Karolinska Institutet, Stockholm, Sweden; 4: Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

Novel genetic discoveries detected using diagnostic OMICSs in patients suspected to suffer from multiple acyl-CoA dehydrogenation deficiency

Signe Mosegaard^1,11, Mirjana Gusic^2,3, Yasuhiko Ago⁴, Xiao Yue⁴, Vincente Yépez^3,5, Julien Gagneur^3,5, Robert Kopajtich³, Dmitrii Smirnov³, Sarah Stenton², Robert Barski⁶, Mark Sharrard⁷, Stanley H. Korman⁸, Jolanta Sykut-Cegielska⁹, Anibh M. Das¹⁰, Helle H. Nygaard¹¹, Margrethe Kjeldsen¹¹, Yusof Rahman¹², Skadi Beblo¹³, Mirian C. H. Janssen¹⁴, Eva Morava¹⁵, Leo A. J. Kluijtmans¹⁶, Alexander Asamoah¹⁷, Emma Buckley¹⁸, Isaque Qureshi¹⁸, Godfrey T. Gillett¹⁹, Ole H. Larsen²⁰, Niels Gregersen¹¹, Toshiyuki Fukao^4,21, Hideo Sasai⁴, Simon Olpin²², Holger Prokisch^2,3, Rikke K. J. Olsen¹¹

1: Laboratory Genetic Metabolic Diseases, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Gastroenterology, Endocrinology, and Metabolism, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands; 2: Institute of Neurogenomics, Helmholtz Zentrum München, Germany; 3: Institute of Human Genetics, School of Medicine, Technical University Munich, München, Germany.; 4: Department of Pediatrics, Graduate School of Medicine, Gifu University Hospital, Gifu, Japan.; 5: Department of Informatics, Technical University of Munich, Garching, Germany.; 6: Department of Biochemical Genetics, St James's University Hospital, Leeds, UK.; 7: Department of Pediatrics, Sheffield Children's Hospital, Sheffield, UK.; 8: Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel.; 9: Department of Inborn Errors of Metabolism and Paediatrics, The Institute of Mother and Child, Warsaw, Poland.; 10: Department of Pediatrics, Hannover Medical School, Hannover, Germany.; 11: Research Unit for Molecular Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.; 12: Center for Inherited Metabolic Disorders, Guy’s & St Thomas’ Hospital NHS Foundation Trust, London, UK.; 13: University Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany.; 14: Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.; 15: Department of Clinical Genomics, Mayo Clinic, Rochester, Minnesota, USA; 16: Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands.; 17: UofL Physicians Novak Center for Children's Health, Louisville, USA.; 18: Nottingham Children’s Hospital, Nottingham University Hospitals NHS Trust, Queen's Medical Centre, Nottingham, UK; 19: Sheffield Teaching Hospitals NHS Trust, University of Sheffield, Sheffield, UK; 20: Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; 21: Clinical Genetics Center, Gifu University Hospital, Gifu, Japan.; 22: Department of Clinical Chemistry, Sheffield Children’s Hospital, Sheffield, UK.

The Australian genomics mitochondrial flagship: a national program delivering mitochondrial diagnoses

David Thorburn^1,2,3, Naomi Baker^2,3, Shanti Balasubramaniam⁴, Stephanie Best⁵, Kaustuv Bhattacharya⁴, Kristen Boggs⁴, Sarah Borrie⁶, Drago Bratkovic⁶, Jeffrey Braithwaite⁵, Alessandra Bray⁴, Jo Burke⁷, David Coman^8,9, Alison Compton^1,2, Mark Cowley¹⁰, Martin Delatycki^2,3, Michelle de Silva^1,2,3, Carolyn Ellaway⁴, Michael Fahey¹¹, Janice Fletcher¹², Leah Frajman^1,2, Ann Frazier^1,2, Velimer Gayeskiv⁹, Roula Ghaoui¹², Himanshu Goel¹³, Ilias Goranitis², Daniella Hock², Denise Howting¹⁴, Matilda Jackson⁶, Maina Kava¹⁵, Sarah King-SMith⁶, Nicole Lake^1,16, Phillipa Lamont^15,17, Joy Lee^2,18, Janet Long⁵, Mandi MacShane¹⁵, Ellenore Martin⁴, Jim McGill⁸, Sean Murray¹⁹, Julie Panetta¹¹, Liza Phillips²⁰, Michael Quinn²¹, Rocio Rius^1,2, Michael Ryan²², Nicholas Smith⁶, David Stroud^1,2,3, Michel Tchan²³, Melanie Tom²¹, Matthew Wallis⁷, Tyson Ware²⁴, AnneMarie Welch¹, Christine Wools¹¹, Eunice Wu², John Christodoulou^1,2,3

1: Murdoch Children's Research Institute, Melbourne, Australia; 2: University of Melbourne, Melbourne, Australia; 3: Victorian Clinical Genetics Services, Melbourne,; 4: Sydney Children’s Hospitals Network, Westmead, Australia; 5: Macquarie University, Sydney, Australia; 6: Women’s and Children’s Hospital, Adelaide, Australia; 7: Tasmanian Clinical Genetics Service, Hobart, Australia; 8: Queensland Children’s Hospital, Brisbane, Australia; 9: Wesley Hospital, Brisbane, Australia; 10: Garvan Institute, Sydney, Australia; 11: Royal Melbourne Hospital, Melbourne, Australia; 12: Royal Adelaide Hospital, Adelaide, Australia; 13: John Hunter Hospital, Newcastle, Australia; 14: Harry Perkins Institute of Medical Research, Perth, Australia; 15: Perth Children’s Hospital, Perth, Australia; 16: Yale School of Medicine, New Haven, CT, USA; 17: Royal Perth Hospital, Perth, Australia; 18: Royal Children’s Hospital, Melbourne, Australia; 19: Mito Foundation, Sydney, Australia; 20: Mater Hospital, Brisbane, Australia; 21: Genetic Health Queensland, Brisbane, Australia; 22: Monash University, Melbourne, Australia; 23: Westmead Hospital, Westmead, Australia; 24: Royal Hobart Hospital, Hobart, Australia

A new family with a case of severe early-onset muscle fatigue and a peculiar maternally inherited painful swelling in chewing muscles associated with homoplasmic m.15992A>T mutation in mitochondrial tRNAPro

Irene Bruno¹, Elena Ghirigato², Mirko Baglivo³, Francesca Terenzi², Nadia Zanetti³, Massimo Zeviani¹, Eleonora Lamantea³

1: Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy; 2: Department of Medicine, Surgery, and Health Sciences, University of Trieste, Trieste, Italy; 3: Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

A novel MT-ATP6 variant associated with complicated ataxia in two unrelated Italian patients: case report and functional studies. 

Daniele Sala¹, Silvia Marchet¹, Lorenzo Nanetti¹, Andrea Legati¹, Caterina Mariotti¹, Eleonora Lamantea¹, Daniele Ghezzi^1,2, Alessia Catania¹, Costanza Lamperti¹

1: Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta; 2: Department of Pathophysiology and Transplantation (DEPT), University of Milan

Biallelic pathogenic variants of PARS2 cause Developmental and Epileptic Encephalopathy with Spike-and-Wave Activation in Sleep

Laura Licchetta¹, Carlotta Stipa¹, Raffaella Minardi¹, Margherita Santucci^1,2, Lucia Di Giorgi^2,3, Martina Soldà¹, Valerio Carelli^1,2, Francesca Bisulli^1,2

1: IRCCS, Istituto delle Scienze Neurologiche di Bologna, Italy; 2: Department of Biomedical and Neuromotor Sciences, University of Bologna, Italy; 3: Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, Italy.

Novel KARS1 mutation causes early-onset lethal cardiomyopathy

Sara Casalini¹, Silvia Buratti¹, Chiara Panicucci¹, Maria Elena Derchi¹, Marco Scaglione¹, Claudia Nesti², Monica Traverso¹, Francesca Madia¹, Michela Di Nottia³, Chiara Fiorillo¹, Valeria Capra¹, Filippo Maria Santorelli², Andrea Moscatelli¹, Rosalba Carrozzo³, Claudio Bruno¹

1: IRCCS Istituto Giannina Gaslini, Genoa; 2: IRCCS Fondazione Stella Maris, Calambrone (PI); 3: IRCCS Ospedale Bambin Gesù, Rome

The ER-MITO (Emilia Romagna-Mitochondrial) project: prevalence and genetics of Chronic Progressive External Ophthalmoplegia (CPEO) in an Italian region

Maria Lucia Valentino^1,2, Leonardo Caporali¹, Chiara La Morgia^1,2, Flavia Palombo¹, Martina Romagnoli¹, Cristina Fonti¹, Alessandra Maresca¹, Rocco Liguori^1,2, Corrado Zenesini¹, Roberto D'Alessandro¹, Valerio Carelli^1,2

1: IRCCS Institute of Neurological Sciences of Bologna, Italy; 2: Department of Biomedical and Neuromotor Sciences, University of Bologna, Italy

UCHL1 missense and loss-of-function variants as an emerging cause of autosomal dominant optic atrophy (ADOA)

Claudio Fiorini¹, Giada Capirossi^1,2, Eleonora Pizzi¹, Federico Sadun³, Maria Lucia Cascavilla⁴, Chiara La Morgia^1,2, Marco Battista⁴, Piero Barboni⁴, Danara Ormanbekova¹, Valentina Del Dotto², Flavia Palombo¹, Valerio Carelli^1,2, Alessandra Maresca¹, Leonardo Caporali²

1: IRCCS Istituto delle Scienze Neurologiche di Bologna, Italy; 2: Department of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, Italy; 3: Ospedale Oftalmico Roma, Rome, Italy; 4: Department of Ophthalmology, University Vita-Salute, IRCCS Ospedale San Raffaele, Milan, Italy

Mitochondrial dysfunction in patients with early-onset UFM1-linked encephalopathy

Samira Ait El Mkadem - Saadi^1,2, Cécile Rouzier^1,2, Annabelle Chaussenot^1,2, Konstantina Fragaki^1,2, Sylvie Bannwarth^1,2, Julien Neveu³, Aline Cano³, Brigitte Chabrol³, Véronique Paquis-Flucklinger^1,2

1: National Centre for Mitochondrial Diseases, Nice Teaching Hospital (CHU de Nice), Department of Medical Genetics, Nice, France; 2: Université Côte d'Azur, CHU, Inserm, CNRS, IRCAN, France; 3: APHM, La Timone Hospital, Department of Neuropediatrics, Marseille, France

A novel dominant variant in the ISCU gene is associated with mitochondrial myopathy

Joanna Rusecka^1,2, Dominika Szczęśniak^2,3, Magdalena Kacprzak², Damian Loska², Kamila Czerska², Agnieszka Sobczyńska-Tomaszewska²

1: Maria Sklodowska-Curie, Medical Academy in Warsaw, Poland; 2: MedGen Medical Center, Warsaw, Poland; 3: Institute of Psychiatry and Neurology, Warsaw, Poland

Expanding the spectrum of clinical presentations associated with COA8 pathogenic

Sara Antognozzi¹, Magi Meneri^1,2, Francesca Magri¹, Manuela Garbellini¹, Sabrina Salani¹, Francesco Fortunato², Michela Ripolone¹, Simona Zanotti¹, Patrizia Ciscato¹, Monica Sciacco¹, Stefania Corti^1,2, Giacomo Pietro Comi^1,2, Dario Ronchi²

1: IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; 2: Dino Ferrari Center, University of Milan, Milan, Italy

A novel mitochondrial DNA variant, m.14430A>C, in MT-ND6 as the likely cause of Leigh syndrome with mitochondrial complex I deficiency.

Surita Meldau^1,2, Gillian T M Riordan^1,3, Sally Ackermann⁴, Sharika Raga^1,3,6, Careni Spencer^1,5, George F Van der Watt^1,2, Kashief Khan², Francois H Van der Westhuizen⁷

1: University of Cape Town, Cape Town, South Africa; 2: National Health Laboratory Sevices, South Africa; 3: Red Cross War Memorial Children's Hospital, Cape Town, South Africa; 4: Constantiaberg Mediclinic, Cape Town, South Africa; 5: Grootte Schuur Hospital, Cape Town, South Africa; 6: Neuroscience Institute, University of Cape Town, Cape Town, South Africa; 7: Human Metabolomics, North-West University, Potchefstroom, South Africa

Leigh syndrome and Fanconi renotubular syndrome are the main clinical phenotype due to mutations in NDUFAF6 gene.

Teresa Rizza¹, Alessandra Torraco¹, Michela Di Nottia¹, Daniela Verrigni¹, Anastasia Altobelli¹, Diego Martinelli¹, Daria Diodato¹, Stephanie Efthymiou², Carlo Dionisi-Vici¹, Enrico Bertini¹, Reza Maroofian², Agnes Rotig³, Rosalba Carrozzo¹

1: Bambino Gesù Children Hospital, Italy; 2: UCL Queen Square Institute of Neurology; 3: Université Paris Descartes, Sorbonne Paris Cité

Mitochondrial encephalomyopathy associated with the m.618T>C in MT-TF

Aryane Silva Coutinho², Tainara Zappia Tessaro¹, Rodrigo Fonseca Vilanova¹, Celia Harumi Tengan²

1: Hospital Municipal Dr. José de Carvalho, Brazil; 2: Escola Paulista de Medicina, Universidade Federal de São Paulo, Brazil

TWNK in Parkinson's disease: a Movement Disorder and Mitochondrial Disease Center perspective study

Marco Percetti^1,2,3, Giulia Franco^3,4, Edoardo Monfrini^3,4, Leonardo Caporali⁵, Raffaella Minardi⁵, Chiara La Morgia⁵, Maria Lucia Valentino^5,6, Rocco Liguori^5,6, Ilaria Palmieri⁷, Donatella Ottaviani⁸, Maria Vizziello³, Dario Ronchi³, Federica Di Berardino⁹, Antoniangela Cocco^10,11, Bertil Macao¹², Maria Falkenberg¹², Giacomo Pietro Comi^3,4, Alberto Albanese¹¹, Bruno Giometto⁸, Enza Maria Valente^7,13, Valerio Carelli^5,6, Alessio Di Fonzo^3,4

1: School of Medicine and Surgery and Milan Center for Neuroscience, University of Milan-Bicocca.; 2: Foundation IRCCS San Gerardo dei Tintori, Monza; 3: Dino Ferrari Center, Neuroscience Section, Department of Pathophysiology and Transplantation, University of Milan, Milan 20122, Italy; 4: Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, Milan, Italy; 5: IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy; 6: Unit of Neurology, Department of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, Bologna, Italy; 7: Neurogenetics Research Center, IRCCS Mondino Foundation, Pavia, Italy; 8: Neurology Unit, Rovereto Hospital, Azienda Provinciale per i Servizi Sanitari (APSS) di Trento, Trento, Italy; 9: Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Audiology Unit, Milan, Italy; 10: University of Milan, Milan, Italy; 11: Department of Neurology, Istituto di Ricovero e Cura a Carattere Scientifico Humanitas, Research Hospital, Milan, Italy; 12: Department of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, SE 405 30 Gothenburg, Sweden; 13: Department of Molecular Medicine, University of Pavia, Pavia, Italy.

Novel pathogenic MT-ND3 variant causing a particular MELAS phenotype

Lucile Riera-Navarro¹, Cécile Rouzier¹, Samira Saadi Ait-El-Mkadem¹, Konstantina Fragaki^1,2, Sylvie Bannwarth^1,2, Pierre Thomas³, Luisa Villa⁴, Véronique Paquis Flucklinger^1,2, Annabelle Chaussenot¹

1: CHU de Nice, France; 2: Université Côte d'Azur, CNRS, INSERM, IRCAN; 3: Service de Neurologie- Hôpital Pasteur 2, CHU de Nice; 4: Centre de référence des Maladies neuromusculaires

Mitochondrial molecular genetic findings in the South African diagnostic setting

Surita Meldau^1,2, Elizabeth Patricia Owen^1,2, Kashief Khan², Gillian Tracy Riordan³

1: University of Cape Town, Cape Town, South Africa; 2: National Health Laboratory Sevices, South Africa; 3: Red Cross War Memorial Children's Hospital, Cape Town, South Africa

Known genes, new genes and new phenotypes in inherited mitochondrial eye diseases

Neringa Jurkute^1,2,3, Gavin Arno^1,2,4, Patrick Yu-Wai-Man^1,2,5,6, Andrew R Webster^1,2

1: Moorfields Eye Hospital NHS Foundation Trust, London, UK; 2: Institute of Ophthalmology, University College London, London, UK; 3: The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK; 4: North Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK; 5: John van Geest Centre for Brain Repair and MRC Mitochondrial Biology Unit, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK; 6: Cambridge Eye Unit, Addenbrooke’s Hospital, Cambridge University Hospitals, Cambridge, UK

LHON spectrum disorder: new phenotypes and genotypes

Marco Battista¹, Leonardo Caporali², Enrico Borrelli¹, Giorgio Lari¹, Alice Galzignato³, Claudio Fiorini², Paolo Nucci⁴, Francesco Bandello¹, Maria Lucia Cascavilla¹, Valerio Carelli^2,5, Piero Barboni¹

1: San Raffaele Hospital, Italy; 2: IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica (Bologna, Italy); 3: Studio Oculistico d’Azeglio (Bologna, Italy); 4: Department of Clinical Science and Community Health, University of Milan, (Milan, Italy); 5: Unit of Neurology, Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna (Bologna, Italy)

Chronic asymmetric progressive external ophthalmoplegia without eyelid weakness

Jae Ho Jung

Seoul National University Hospital, Korea, Republic of (South Korea)

Bayesian inference enables discovery of functional effects of heteroplasmic mitochondrial mutations in the developing brain

Aidan Scott Marshall, Yue Nie, Nick.S Jones, Patrick.F Chinnery

Imperial College London, United Kingdom

Cell lineage-specific mitochondrial gene expression is established in the early embryo, prior to organ maturation

Stephen P. Burr^1,2, Florian Klimm^1,2,3, Angelos Glynos^1,2, Malwina Prater^1,2,4, James B. Stewart^5,6, Patrick F. Chinnery^1,2, Michele Frison^1,2

1: Department of Clinical Neurosciences, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK; 2: Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK; 3: Novo Nordisk Research Centre Oxford, Innovation Building, University of Oxford, Old Road Campus, Oxford, UK; 4: Functional Genomics Centre, Milner Therapeutics Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK; 5: Max Planck Institute for Biology of Ageing, Cologne, Germany; 6: Biosciences Institute, Faculty of Medical Sciences, Wellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK

Identifying mitochondrial methyltransferases using unbiased proteome-ligand profiling

Alissa Wilhalm¹, David Moore¹, Florian Rosenberger¹, Anna Wedell², Christoph Freyer¹, Anna Wredenberg^1,2

1: Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden, Sweden; 2: Centre of Inherited metabolic diseases, Karolinska University Hospital, Stockholm, Sweden

Engineering mitochondrial aminoacyl-tRNA synthetases as a tool to investigate mitochondrial protein synthesis

Christin A Albus, Ellyn N Willsher, Syeda Z Akthar, Robert N Lightowlers, Zofia MA Chrzanowska-Lightowlers

Newcastle University, United Kingdom

Short-read NGS for the screening of structural and copy number alterations in mtDNA as powerful diagnostic tool.

Christiane Neuhofer^1,2, Rossella Izzo³, Riccardo Berutti^1,2, Martin Pavlov², Eleonora Lamantea³, Elisabeth Graf¹, Costanza Lamperti³, Thomas Klopstock⁴, Holger Prokisch^1,2, Daniele Ghezzi^3,5, Andrea Legati³

1: Institute of Human Genetics, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, (Munich, Germany); 2: Institute of Neurogenomics, Helmholtz Zentrum München (Neuherberg, Germany); 3: Fondazione IRCCS Istituto Neurologico Carlo Besta (Milan, Italy); 4: Department of Neurology, Friedrich-Baur-Institute, LMU Hospital, Ludwig Maximilians University (Munich, Germany); 5: Department of Pathophysiology and Transplantation, University of Milan (Milan, Italy)

Ethical dilemmas and diagnostic uplifts; primary mitochondrial disease the era of first line whole genome sequencing

William L. Macken^1,2, Rachel L. Horton^3,4, Michael G. Hanna^1,2, Anneke M. Lucassen^3,4, Robert D.S. Pitceathly^1,2

1: UCL Queen Square Institute of Neurology, United Kingdom; 2: NHS Highly Specialised Service for Rare Mitochondrial Disorders, Queen Square Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, London, UK.; 3: Centre for Personalised Medicine, and Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK; 4: Clinical Ethics, Law and Society, Faculty of Medicine, University of Southampton, Southampton, UK

Analysis of mitochondrial metabolism using 13C-labeled mass isotopologue analysis and mass spectrometry as a new approach for the diagnostics of mitochondrial disorders

Liesbeth T. Wintjes¹, Arno van Rooij¹, Sacha Hendriks¹, Coby M. Laarakkers¹, Richard J.T. Rodenburg^1,2

1: Department of Genetics, Translational Metabolic Laboratory, Radboudumc, Nijmegen, The Netherlands.; 2: Department of Pediatrics, Radboud Centre for Mitochondrial Medicine, Radboudumc, Nijmegen, The Netherlands

Subcellular metabolomics: a pipeline for compartment-specific metabolic investigations in a mouse model of Leigh syndrome

Gunter van der Walt, Jason Elferink, Zander Lindeque, Shayne Mason, Roan Louw

North-West University, South Africa

High‐content screening for modulators of mitochondria‐ER contact sites and identification of their protein targets

Tomas Knedlik¹, Federica Dal Bello¹, Marta Giacomello^1,2

1: Department of Biology, University of Padova, Italy; 2: Department of Biomedical Sciences, University of Padova, Italy

A novel Approach to assess the pathogenicity of mtDNA Variants

Omar Tutakhel, Frans van den Brandt, Kai Francke, Hatice Nur Ozhan, Frans Maas, Daan Panneman, Liesbeth Wintjes, Roel Smeets, Dirk Lefeber, Bert van den Heuvel, Richard J. Rodenburg

RadboudUMC, Translational Metabolic Laboratory, Dept of Pediatrics, Nijmegen, The Netherlands

At the core of the apoptotic foci

Hector Flores-Romero, Aida Peña Blanco, Lisa Hohorst, Jonas Aufdermauer, Shashank Dadsena, Cristiana Zollo, Rodrigo Cuevas-Arenas, Ana J. Garcia-Saez.

CECAD, Germany

Clinical utility of ultra-rapid genomic testing for infants and children with a suspected mitochondrial disorder

John Christodoulou^1,2,3,4, Sophie Bouffler⁵, Chirag Patel⁶, Sarah Sandaradura^4,7, Meredith Wilson^4,7,8, Jason Pinner^8,9, Matthew Hunter^10,11, Christopher Barnett^12,13,14, Mathew Wallis^15,16, Benjamin Kamien¹⁷, Tiong Tan^1,2,3, Mary-Louise Freckmann¹⁸, Karin Kassahn^13,14, Tony Roscioli^19,20,21, Alison Compton^1,2,3, David Thorburn^1,2,3, Sebastian Lunke^1,2,3,5, Zornitza Stark^1,2,3,5

1: Murdoch Children's Research Institute, Melbourne, Australia; 2: University of Melbourne, Melbourne, Australia; 3: Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Australia; 4: University of Sydney, Sydney, Australia; 5: Australian Genomics, Melbourne, Australia; 6: Genetic Health Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; 7: Sydney Children’s Hospitals Network – Westmead, Sydney, Australia; 8: Sydney Children’s Hospitals Network – Randwick, Sydney, Australia; 9: University of New South Wales, Sydney, Australia; 10: Monash Genetics, Monash Health, Melbourne, Australia; 11: Department of Paediatrics, Monash University, Melbourne, Australia; 12: Paediatric and Reproductive Genetics Unit, Women’s and Children’s Hospital, North Adelaide, Australia; 13: Adelaide Medical School, The University of Adelaide, Adelaide, Australia; 14: Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia; 15: Tasmanian Clinical Genetics Service, Tasmanian Health Service, Hobart, Australia; 16: School of Medicine and Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia; 17: Genetic Services of Western Australia, Perth, Australia; 18: Department of Clinical Genetics, The Canberra Hospital, Canberra, Australia; 19: Centre for Clinical Genetics, Sydney Children's Hospital, Sydney, NSW, Australia; 20: Randwick Genomics Laboratory, NSW Health Pathology, Prince of Wales Hospital, Sydney, Australia; 21: Neuroscience Research Australia (NeuRA) and Prince of Wales Clinical School, UNSW, Sydney, Australia

Contribution of RNA-seq to diagnosis and determination of functional impact of candidate variants in 45 patients suspected of mitochondrial disease.

Gerard Muñoz-Pujol¹, Olatz Ugarteburu¹, Blai Morales¹, Judit García-Villoria¹, Laura Gort¹, Vicente A. Yépez², Julien Gagneur², Mirjana Gusic², Holger Prokisch², Marc Dabad³, Anna Esteve-Codina³, Antonia Ribes¹, Frederic Tort¹

1: Secció d'Errors Congènits del Metabolisme-IBC, Servei de Bioquímica i Genètica Molecular, Hospital Clínic de Barcelona, IDIBAPS, CIBERER, Barcelona, Spain; 2: Institute of Human Genetics, School of Medicine, Technical University of Munich, Munich, Germany; 3: CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology and Universitat Pompeu Fabra, Barcelona, Spain

Dynamics of NAD and glutathione metabolites in blood during aging, in disease and upon supplementation with NAD-booster

Liliya Euro^1,2, Kimmo Haimilahti¹, Sonja Jansson^1,2, Jana Buzkova^1,2, Anu Suomalainen-Wartiovaara^1,3

1: University of Helsinki, Finland; 2: NADMED Ltd, Finland; 3: HUS Diagnostic Centre, Finland

Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation

Marc Sunden^1,2, Divya Upadhyay^1,2, Rishi Banerjee^1,2, Nina Sipari³, Vineta Fellman^1,2,4, Jukka Kallijarvi^1,2, Janne Purhonen^1,2

1: Folkhalsan Research Center, Finland; 2: Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Finland; 3: Viikki Metabolomics Unit, University of Helsinki, Finland; 4: Children’s Hospital, Helsinki University Hospital, Finland

Genetic testing for mitochondrial disease: The United Kingdom best practice guidelines

Eleni Mavraki^1,2, Robyn Labrum³, Kate Sergeant⁴, Charlotte L Alston^1,2, Cathy Woodward³, Conrad Smith⁴, Charlotte V Y Knowles^1,2, Yogen Patel³, Philip Hodsdon⁴, Jack P Baines^1,2, Emma L Blakely^1,2, James Polke³, Robert W Taylor^1,2, Carl Fratter⁴

1: NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; 2: Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK; 3: Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK; 4: Oxford Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Identification of uncharacterized genes involved in mitochondrial OXPHOS function and integrity.

Marcos Javier Zamora Dorta, Sara Laine Menéndez, David Abia Holgado, Eduardo Balsa Martínez

Centro de Biología Molecular Severo Ochoa, Spain

Investigating the role of mito-nuclear genetic variation in determining m.3243A>G variant heteroplasmy

Alia K. Saeed¹, Róisín M. Boggan¹, Imogen G. Franklin¹, Charlotte L. Alston^1,2, Emma L. Blakely^1,2, Boriana Büchner³, Enrico Bugiardini⁴, Kevin Colclough⁵, Gráinne S. Gorman¹, Catherine Feeney¹, Michael G. Hanna⁴, Andrew T. Hattersley⁶, Thomas Klopstock^3,7,8, Cornelia Kornblum⁹, Michelangelo Mancuso¹⁰, Yi Shiau Ng¹, Kashyap A. Patel⁶, Robert D. S. Pitceathly⁴, Chiara Pizzamiglio⁴, Holger Prokisch^11,12, Jochen Schäfer¹³, Andrew M. Schaefer¹, Maggie H. Shepherd⁶, Annemarie Thaele¹⁴, Doug M. Turnbull¹, Cathy E. Woodward¹⁵, Heather J. Cordell¹⁶, Robert McFarland¹, Robert W. Taylor^1,2, Gavin H. Hudson¹, Sarah J. Pickett¹

1: Wellcome Centre for Mitochondrial Research and Institute for Translational and Clinical Research, Newcastle University, Newcastle upon Tyne, UK; 2: NHS Highly Specialised Mitochondrial Diagnostic Laboratory, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; 3: Department of Neurology, Friedrich-Baur-Institute, University Hospital of the Ludwig-Maximilians-University (LMU Klinikum), Munich, Germany; 4: Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK; 5: Exeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK; 6: Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK; 7: Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; 8: German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; 9: Department of Neurology, University Hospital Bonn, Bonn, Germany; 10: Neurological Institute of Pisa, Italy; 11: Institute of Human Genetics, School of Medicine, Technische Universität München, München, Germany; 12: Institute of Neurogenomics, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany; 13: Department of Neurology, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; 14: Department of Neurology, Martin-Luther-University Halle-Wittenberg, 06120 Halle (Saale), Germany; 15: Neurogenetics Unit, The National Hospital for Neurology and Neurosurgery, London, UK; 16: Population Health Sciences Institute, Newcastle University, UK

Mitochondrial DNA depletion and deletion analysis using smMIPs

Maaike Brink^1,2, Sanne van Kraaij^1,2, Sanne Sweegers^1,2, Roel Smeets^1,2, Richard Rodenburg^1,2,3

1: Translational Metabolic Laboratory, Radboudumc, Nijmegen, The Netherlands; 2: Radboud Center for Mitochondrial Medicine (RCMM), Radboudumc, Nijmegen, The Netherlands; 3: Department of Pediatrics, Radboudumc, Nijmegen, The Netherlands

Ultrastructure of mitochondria in 3D from volume electron microscopy

Chenhao Wang^1,2, Leif Østergaard^3,4, Stine Hasselholt^3,4, Jon Sporring^1,2

1: Department of Computer Science, University of Copenhagen, Denmark; 2: Center for Quantification of Imaging Data from MAX IV; 3: Department of Clinical Medicine, Aarhus University, Denmark; 4: Center of Functionally Integrative Neuroscience

Visualizing ATP dynamics in living mice

Masamichi Yamamoto, Jungmi Choi

National Cerebral and Cardiovascular Center, Japan

Applying sodium carbonate extraction mass spectrometry to investigate defects in the mitochondrial respiratory chain

David Robert Lindsay Robinson¹, Daniella Hock¹, Linden Muellner-Wong^1,2, Roopingsam Kugapreethan¹, Boris Reljic^1,3, Elliot Surgenor^3,4, Carlos Rodrigues^1,5, Nikeisha Caruana^1,6, David Stroud^1,2

1: Department of Biochemistry and Pharmacology, University of Melbourne, Melbourne, Australia; 2: Murdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, Australia; 3: Department of Biochemistry and Molecular Biology, Monash University, Melbourne,Australia; 4: The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; 5: Baker Heart and Diabetes Institute, Melbourne, Australia; 6: Institute for Health and Sport (IHES), Victoria University, Melbourne, Australia

Global analysis of protein methylation in the mitochondrial compartment of cancer cells: a proteomic approach

Ayusi Mondal^1,2, Alessandro Vai^1,2, Silvia Pedretti^1,3, Marianna Maniaci¹, Nico Mitro^1,3, Tiziana Bonaldi^1,4

1: Department of Experimental Oncology, European Institute of Oncology (IEO), IRCCS Milano, Italy; 2: European School of Molecular Medicine (SEMM); 3: Department of Pharmacological and Biomolecular Sciences, University of Milan, Italy; 4: Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy

MITODIAG : The French network of diagnostic laboratories for mitochondrial diseases

Cécile Rouzier¹, Emmanuelle Pion², Céline Bris³, Patrizia Bonneau³, Valérie Desquiret³, Jean-Paul Bonnefont⁴, Pauline Gaignard⁵, Elise Lebigot⁵, Samira Ait-El-Mkadem Saadi¹, Sylvie Bannwarth¹, Konstantina Fragaki¹, Benoit Rucheton⁶, Marie-Laure Martin-Negrier⁷, Aurélien Trimouille⁷, Cécile Acquaviva-Bourdain⁸, Cécile Pagan⁸, Anne-Sophie Lebre⁹, Gaelle Hardy¹⁰, Stéphane Allouche¹¹, Pascal Reynier³, Mireille Cossee¹², Sharam Attarian¹³, Véronique Paquis-Flucklinger¹, Vincent Procaccio³

1: Service de génétique médicale, Centre de référence des maladies mitochondriales, CHU Nice, Université Cote d’Azur, CNRS, INSERM, IRCAN, Nice; 2: Filnemus, laboratoire de génétique moléculaire, CHU Montpellier; 3: Service de génétique, Institut de Biologie en santé, Centre National de référence Maladies Neurodégénératives et Mitochondriales, CHU Angers; 4: Fédération de génétique médicale, Service de génétique moléculaire du GH Necker-enfants malades, Hôpital Necker-Enfants Malades, Paris; 5: Laboratoire de Biochimie, Pôle BPP, CHU Paris Sud, Hôpital Bicêtre-le Kremlin Bicêtre, Paris; 6: Pôle de biologie et pathologie, CHU Bordeaux; 7: Unité fonctionnelle d’histologie moléculaire, Service de pathologie, CHU Bordeaux-GU Pellegrin, Bordeaux; 8: Service de biochimie et biologie moléculaire Grand Est, UM Maladies Héréditaires du Métabolisme, Centre de biologie et pathologie Est, CHU Lyon HCL, GH Est, Lyon; 9: Laboratoire de génétique, Hématologie et Immunologie, CHU Reims; 10: Laboratoire de génétique moléculaire: maladies héréditaires et oncologie, Service de biochimie, biologie moléculaire et toxicologie environnementale, CHU Grenoble et des Alpes, Institut de biologie et pathologie, Grenoble; 11: Service de biochimie, Pôle Biologie, Pharmacie et Hygiène, CHU Caen, Hôpital de la Côte de Nacre, Caen; 12: Laboratoire de Génétique Moléculaire, CHU Montpellier, PhyMedExp, Université de Montpellier, INSERM, CNRS, Montpellier; 13: Filnemus, Assistance Publique Hôpitaux Marseille, Service de Neurologie, Hôpital La Timone, Marseille

Multiomic mitochondrial and metabolic screening reveals potential biomarkers in inclusion body myositis

Judith Cantó Santos^1,2,3, Laura Valls Roca^1,2,3, Ester Tobías^1,2,3, Clara Oliva⁴, Francesc Josep García-García^1,2,3, Mariona Guitart Mampel^1,2,3, Félix Andújar Sánchez^1,2,3, Laia Farré Tarrats^1,2,3, Joan Padrosa^1,2,3, Raquel Aránega^1,2,3, Pedro J. Moreno Lozano^1,2,3, José César Milisenda^1,2,3, Rafael Artuch⁴, Josep M. Grau Junyent^1,2,3, Glòria Garrabou^1,2,3

1: Hereditary Metabolic Diseases and Muscular Diseases Lab, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain; 2: Department of Internal Medicine, Hospital Clinic of Barcelona, Barcelona, Spain; 3: CIBERER— Spanish Biomedical Research Centre in Rare Diseases, Madrid, Spain; 4: Department of Clinical Biochemistry, Institut de Recerca Sant Joan de Déu; Esplugues de Llobregat, Barcelona, Spain

Network analysis of protein-protein interactions identifies intermediate filaments as a novel mitochondrial dynamics related structure

Irene M.G.M. Hemel, Carlijn Steen, Michiel Adriaens, Mike Gerards

Maastricht Centre for Systems Biology (MaCSBio), Maastricht University, The Netherlands

Establishment of mitochondrial proline metabolic disorder patient-derived induced pluripotent stem cells as a new cellular model for aging associated disease study

Yu-Wen Huang, Tsung-Han Lee, Dar-Shong Lin

Mackay Memorial Hospital, Taiwan

Mitochondrial disorders unraveled by NGS technologies

Yulia Itkis¹, Tatiana Krylova¹, Natalia Pechatnikova², Ekaterina Zakharova¹

1: Research centre for medical genetics, Russian Federation; 2: Morozov's Moscow City Child Clinical Hospital, Moscow, Russia

Incorporation of exogenous mitochondria into cells and their effects on the cells

Hisashi Ohta^1,2, Yosif El-Darawish^1,2, Masae Takeda^1,2, Takahiro Shibata^1,2, Keiichi Sakakibara^1,2, Rick Tsai¹, Masashi Suganuma¹

1: LUCA Science, Japan; 2: Biological Drug Development based DDS technology, Hokkaido Univ.

Mitochondrial encapsulation technology for mitochondrial transplantation therapy

Yonghui Wang^1,2, Oliver Koivisto^1,2, Chang Liu^1,2, Hongbo Zhang^1,2

1: Pharmaceutical Sciences Laboratory, Åbo Akademi University, Finland; 2: Turku Bioscience Centre, University of Turku and Åbo Akademi University

Inhibition of mtDNA transcription in liver reverses diet-induced obesity and hepatosteatosis in the mouse

Shan Jiang¹, Taolin Yuan¹, Laura Kremer¹, Florian Schober², Fynn Hansen², Diana Rubalcava-Gracia¹, Mara Mennuni¹, Roberta Filograna¹, David Alsina¹, Jelena Misic¹, Patrick Giavalisco³, Matthias Mann², Nils-Göran Larsson¹

1: Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Sweden; 2: Max-Planck Institute of Biochemistry, Martinsried, Germany; 3: Metabolomics Core Facility, Max Planck Institute for Biology of Ageing, Cologne, Germany

The mitochondrial phenotype of Leigh syndrome SURF1 mutant patient-derived fibroblasts and recovery using small molecules

Rachel M Hughes¹, Laura M Ellis¹, Naomi Hartopp¹, Emily Mossman¹, Gauri Bhosale², Annachiara Gandini², Alessandro Pristera², Christopher Doe², Scott P Allen¹, Oliver Bandmann¹, Laura Ferraiuolo¹, Pamela J Shaw¹, Heather J Mortiboys¹

1: Sheffield Institute for Translational Neuroscience, University of Sheffield, United Kingdom; 2: Nanna Therapeutics, Cambridge, United Kingdom

Knockout of Complex III subunit Uqcrh decreases respiratory capacity and impairs cardiac contractile function independent of mitochondrial ROS production

Nadine Spielmann^1,9, Christina Schenkl^2,9, Tímea Komlódi^3,4, Patricia da Silva-Buttkus¹, Estelle Heyne², Jana Rohde¹, Oana V. Amarie¹, Birgit Rathkolb^1,5,6, Erich Gnaiger³, Torsten Doenst², Helmut Fuchs¹, Valérie Gailus-Durner¹, Martin Hrabě de Angelis^1,6,7,9, Marten Szibor^2,8,9

1: Institute of Experimental Genetics, German Mouse Clinic, Helmholtz Center Munich, German Research Center for Environmental Health, Germany; 2: Jena University Hospital, Friedrich-Schiller University of Jena, Germany; 3: Oroboros Instruments, Innsbruck, Austria; 4: Department of Biochemistry and Molecular Biology, Semmelweis University Budapest, Hungary; 5: Institute of Molecular Animal Breeding and Biotechnology, Gene Center, Ludwig-Maximilians-Universität München, Germany; 6: Member of German Center for Diabetes Research (DZD), Germany; 7: Chair of Experimental Genetics Experimental Genetics, School of Life Science Weihenstephan, Technische Universität München, Germany; 8: BioMediTech & Tampere University Hospital, Faculty of Medicine and Health Technology, Tampere University, Finland; 9: Contributed equally

Molecular insights into the role of complex V deficiency in heart development, function and disease

Mario Pavez-Giani^1,2, Karen an der Brügge¹, Till Stephan⁴, Felix Lange⁴, Jakob Fell^1,2, Alessandro Prigione³, Stefan Jakobs⁴, Lukas Cyganek^1,2

1: Stem Cell Unit, Clinic for Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany; 2: German Center for Cardiovascular Research (DZHK), partner site Göttingen, Germany; 3: Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany; 4: Research Group Mitochondrial Structure and Dynamics, Department of NanoBiophotonics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany

Establishing mammalian cell models for research of NDUFS1-associated diseases

Lena Jentsch¹, Laura Schröter², Natascia Ventura^1,2

1: Heinrich Heine University Düsseldorf, Germany; 2: IUF- Leibniz Research Institute for Environmental Medicine

A neuronal model of mtDNA disease reveals a compensatory reprogramming of the electron transfer chain during neuronal maturation

Shane Thomas Bell¹, Rebeca Acín-Pérez², Iffath Ghouri¹, Orian Shirihai², Robert Lightowlers¹, Oliver Russell¹

1: Wellcome Centre for Mitochondrial Research, Newcastle University, United Kingdom; 2: Metabolism Theme, David Geffen School of Medicine, University of California, Los Angeles (UCLA), CA, USA

Development of mutant mtDNA-targeted TALENs and their application to iPSC-based mitochondrial disease model.

Naoki Yahata, Ryuji Hata

Fujita Health University School of Medicine, Japan

Deficits in mitochondrial oxidative phosphorylation enhance SARS-CoV-2 replication

Yentli E. Soto Albrecht^1,2, Ryan Morrow¹, Arnold Olali¹, Devin Kenney^3,4, Prasanth Potluri¹, Deborah Murdock¹, Alessia Angelin¹, Florian Douam^3,4, Douglas C. Wallace^1,2

1: Children's Hospital of Philadelphia, USA; 2: University of Pennsylvania, USA; 3: Boston University, USA; 4: National Emerging Infectious Diseases Laboratories, Boston, USA

Metabolic analysis of mouse sarcopenic skeletal muscle identifies new strategies to increase lifespan in C. elegans

Steffi M Jonk¹, Vicki Chrysostomou², James R Tribble¹, Jonathan G Crowston^2,3,4, Peter Swoboda¹, Pete A Williams¹

1: Karolinska Institutet, Sweden; 2: Centre for Vision Research Duke-NUS & Singapore National Eye Centre, Singapore; 3: Save Sight Institute at the University of Sydney, Australia; 4: The University of Melbourne, Australia.

Delineating mitochondrial pathology using a genome-wide CRISPR/Cas9 activation screen

Yasmin Tang¹, Angela Pyle¹, Krutik Patel¹, Robert McFarland^1,2, Robert W. Taylor^1,2, Monika Oláhová¹

1: Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE2 4HH; 2: NHS Highly Specialised Rare Mitochondrial Disorders Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE2 4HH

Cancer and cellular senescence – two complementary stress models to study turnover and quality control of mitochondrial respiratory complexes.

Hanna Salmonowicz^1,2, Mahdi S Mahdi^1,2, Deepti Mudartha¹, Szymon Gorgon^1,2, Stadnik Dorota^1,2, Remigiusz Serwa^1,2, Karolina Szczepanowska^1,2

1: IMol Polish Academy of Sciences, Poland; 2: ReMedy International Research Agenda

Proteotoxicity induced mitochondrial integrated stress response in CHCHD10-linked adult-onset spinal muscular atrophy

Sandra Harjuhaahto¹, Bowen Hu¹, Jouni Kvist¹, Fuping Zhang^2,3, Tomas Zárybnický², Kimmo Haimilahti⁴, Eija Pirinen⁴, Emilia Kuuluvainen², Ville Hietakangas^2,5, Satu Kuure^2,3, Manu Jokela^6,7, Emil Ylikallio^1,8, Henna Tyynismaa¹

1: Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki; 2: Helsinki Institute of Life Science HiLIFE, University of Helsinki; 3: Genetically Modified Rodents Unit, Laboratory Animal Center, University of Helsinki; 4: Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki; 5: Faculty of Biological and Environmental Sciences, University of Helsinki; 6: Division of Clinical Neurosciences, Turku University Hospital and University of Turku; 7: Department of Neurology, Neuromuscular Research Center, Tampere University Hospital and Tampere University; 8: Clinical Neurosciences, Neurology, Helsinki University Hospital

Protective role of mitochondrial stress signaling and fragmentation in mitochondrial cardiomyopathy

Sofia Ahola, Lilli Pazurek, Fiona Mayer, Hendrik Nolte, Thomas Langer

Max Planck Institute for Biology of Ageing, Cologne, Germany

The Italian reappraisal on the most frequent genetic defects in hereditary optic neuropathies and the global top 10

Claudio Fiorini¹, Danara Ormanbekova¹, Flavia Palombo¹, Alberto Pasti¹, Michele Carbonelli², Giulia Amore², Martina Romagnoli², Pietro D'Agati², Maria Lucia Valentino^1,2, Piero Barboni³, Maria Lucia Cascavilla³, Anna Maria De Negri⁴, Federico Sadun⁵, Arturo Carta⁶, Francesco Testa⁷, Vittoria Petruzzella⁸, Silvana Guerriero⁸, Stefania Bianchi Marzoli⁹, Valerio Carelli^1,2, Chiara La Morgia^1,2, Leonardo Caporali²

1: IRCCS Istituto di Scienze Neurologiche di Bologna, Programma di Neurogenetica, Bologna, Italy; 2: Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy; 3: Department of Ophthalmology, University Vita-Salute, IRCCS Ospedale San Raffaele, Milan, Italy; 4: Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy; 5: Ospedale Oftalmico Roma, Rome, Italy; 6: Ophthalmology Unit, University Hospital of Parma, Parma, Italy; 7: Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli, Naples, Italy; 8: Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari Aldo Moro, Bari, Italy; 9: Neuroophthalmology Service and Ocular Electrophysiology laboratory, Department of Ophthalmology, IRCCS Istituto Auxologico Italiano, Milan, Italy

Aberrant ER-mitochondria communication in human mitochondrial disease

Eric A. Schon¹, Khushbu Kabra¹, Patricia Morcillo¹, Delfina Larrea¹, Estela Area-Gomez^1,2, Orhan Akman¹

1: Columbia University, USA; 2: Centro de Investigaciones Biológicas “Margarita Salas”, Madrid, Spain

Mitochondrial F0F1-ATP synthase conditions the responsiveness of mitochondria to fission

Charlène Lhuissier¹, Julien Cassereau³, Valérie Desquiret-Dumas², Guy Lenaers¹, Naïg Gueguen², Arnaud Chevrollier¹

1: MITOVASC Université d'Angers, France; 2: Departments of Biochemistry and Molecular Biology, University Hospital Angers, Angers, France; 3: Laboratoire de Neurobiologie et Neuropathologie, Centre Hospitalier Universitaire d'Angers, Angers, France

A screening method for mitochondrial disorders by high-resolution respirometry

Kersti Tepp¹, Kairit Joost², Natalja Timohhina¹, Marju Puurand¹, Tuuli Kaambre¹

1: National Institute of Chemical Physics and Biophysics, Estonia; 2: Clinic of Internal Medicine, East-Tallinn Central Hospital, Estonia

AK3, adenylate kinase isozyme 3, is a new gene associated with PEO and multiple mtDNA deletions

Alessia Nasca¹, Andrea Legati¹, Teresa Ciavattini¹, Nadia Zanetti¹, Eleonora Lamantea¹, Javier Ramón², Ramon Martí², Maria Antonietta Maioli³, Costanza Lamperti¹, Holger Prokisch^4,5, Daniele Ghezzi^1,6

1: Fondazione IRCCS Istituto Neurologico Besta, Italy; 2: Vall d'Hebron Research Institute, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Autonomous University of Barcelona, Barcelona, Spain; 3: Centro Sclerosi Multipla, P.O. Binaghi, ASL Cagliari, Italy; 4: Technical University of Munich, School of Medicine, Institute of Human Genetics, 81675 Munich, Germany; 5: Institute of Neurogenomics, Helmholtz Zentrum München, 85764 Munich, Germany; 6: Department of Pathophysiology and Transplantation (DEPT), University of Milan, Italy

Heterozygous missense variants in NUTF2 (nuclear transport factor 2) gene, mapping at the OPA8 locus, cause Dominant Optic Atrophy

Agnese Macaluso¹, Alessandra Maresca¹, Concetta Valentina Tropeano¹, Maria Antonietta Capristo¹, Flavia Palombo¹, Leonardo Caporali¹, Claudio Fiorini¹, Danara Ormanbekova¹, Chiara La Morgia¹, Piero Barboni^2,3, Cristina Villaverde^4,5, Carmen Ayuso^4,5, Maria Esther Gallardo^6,5, Majida Charif⁷, Sylvie Gerber⁸, Patrizia Amati-Bonneau⁷, Guy Lanaers^7,9, Jean-Michel Rozet⁷, Bernd Wissinger¹⁰, Valerio Carelli^1,11, Valentina Del Dotto¹¹

1: IRCCS - Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica - Bologna (Italy); 2: Studio Oculistico d'Azeglio - Bologna (Italy); 3: Department of Ophthalmology, University Vita-Salute, IRCCS Ospedale San Raffaele - Milano (Italy); 4: Department of Genetics & Genomics, Instituto de Investigación Sanitaria - Fundación Jiménez Díaz University Hospital - Universidad Autónoma de Madrid (IIS-FJD-UAM) - Madrid (Spain); 5: Center for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII - Madrid (Spain); 6: Grupo de investigación traslacional con células iPS, Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12), Madrid, Spain; Centro de Investigación Biomédica en Red (CIBERER) - Madrid (Spain); 7: Université d’Angers, MitoLab team, UMR CNRS 6015 - INSERM U1083, Unité MitoVasc - Angers (France); 8: Laboratory of Genetics in Ophthalmology (LGO), INSERM UMR1163, Institute of Genetic Diseases, Imagine and Paris Descartes University - Paris (France); 9: Departments of Biochemistry and Genetics, University Hospital Angers - Angers (France); 10: Molecular Genetics Laboratory, Institute for Ophthalmic Research, Center for Ophthalmology, University of Tübingen, Tübingen, Germany; 11: Depart. of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna - Bologna (Italy)

Southern African paediatric patients with King Denborough syndrome are exclusively associated with an autosomal recessive STAC3 variant: is this a highly prevalent secondary mitochondrial disease in this African population?

Francois Hendrikus van der Westhuizen¹, Maryke Schoonen¹, Michelle Bisschoff¹, Ronel Human², Elsa Lubbe², Malebo Nonyane², Armand Vorster¹, Karin Terburgh¹, Robert McFarland³, Robert Taylor³, Mahmoud Fassad³, Krutik Patel³, Wilson Lindsay⁴, Michael Hanna⁴, Jana Vandrovcova⁴, The ICGNMD Consortium⁵, Izelle Smuts²

1: Human Metabolomics, North-West University, Potchefstroom, South Africa; 2: Department of Paediatrics, Steve Biko Academic Hospital, University of Pretoria, Pretoria, South Africa; 3: Wellcome Centre for Mitochondrial Research, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom; 4: Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United Kingdom; 5: https://www.ucl.ac.uk/genomic-medicine-neuromuscular-diseases/global-contributor-list

Long-read NGS for detection of mitochondrial DNA large-scale deletions and complex rearrangements

Chiara Frascarelli¹, Nadia Zanetti¹, Alessia Nasca¹, Rossella Izzo¹, Costanza Lamperti¹, Eleonora Lamantea¹, Daniele Ghezzi^1,2, Andrea Legati¹

1: Fondazione IRCCS Istituto Neurologico Carlo Besta (Milan, Italy); 2: University of Milan (Milan, Italy)

Quantification of all 12 canonical ribonucleotides by real-time fluorogenic in vitro transcription

Janne Purhonen^1,2, Jukka Kallijarvi^1,2

1: Folkhalsan Research Center, Finland; 2: Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki

Quantifying mitochondrial proteome remodeling during macrophage polarization

Joan Blanco-Fernandez, Manfredo Quadroni, Alexis A. Jourdain

University of Lausanne, Switzerland

Mitochondrial injury in warm ischemia studied by high-resolution respirometry

Alba Timón-Gómez, Luiza HD Cardoso, Eleonora Baglivo, Carolina Doerrier, Erich Gnaiger

Oroboros Instruments GmBH, Austria

MitoCluster: integrated phenotyping and mouse model generation platform for mitochondrial disease and dysfunction

Micol Falabella¹, Patrick F. Chinnery², Laura C. Greaves³, Michael G. Hanna^1,4, Thomas M. Keane⁵, Robert McFarland³, Michal Minczuk², Owen J. Sansom^6,7, James B. Stewart³, Michelle Stewart⁸, Lydia Teboul⁸, Keira Turner², Jelle van den Ameele², Carlo Viscomi⁹, Sara Wells⁸, Alexander J. Whitworth², Robert D. S. Pitceathly^1,4

1: Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK; 2: Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge UK; 3: Wellcome Centre for Mitochondrial Research, Faculty of Medical Sciences, Newcastle University, UK; 4: NHS Highly Specialised Service for Rare Mitochondrial Disorders, Queen Square Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, London, UK; 5: European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK; 6: Cancer Research UK Beatson Institute, Glasgow, UK; 7: Institute of Cancer Sciences, University of Glasgow, Glasgow, UK; 8: Mary Lyon Centre MRC Harwell, UK; 9: University of Padua, Italy

Decoding the regulatory principles of mitochondrial DNA: packaging, expression, and impact on cellular metabolism

L. Stirling Churchman

Harvard Medical School, United States of America

Mechanisms of mitochondrial RNA biogenesis in health and disease

Hauke Hillen^1,2

1: Department of Cellular Biochemistry, University Medical Center Göttingen, Germany; 2: Research Group Structure and Function of Molecular Machines, Max-Planck-Institute for Multidisciplinary Sciences Göttingen, Germany

Disruption of mitochondrial function induces cell lineage-specific compensatory transcriptional responses during early embryonic development

Stephen P. Burr^1,2, Florian Klimm^1,2,3, Angelos Glynos^1,2, Malwina Prater^1,2,4, Maria Falkenberg⁵, Michal Minczuk², James B. Stewart^6,7, Patrick F Chinnery^1,2

1: Department of Clinical Neurosciences, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK; 2: Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK; 3: Novo Nordisk Research Centre Oxford, Innovation Building, University of Oxford, Old Road Campus, Oxford, UK; 4: Functional Genomics Centre, Milner Therapeutics Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK; 5: Department of Medical Biochemistry and Cell Biology, University of Gothenburg, PO Box 440, Gothenburg 405 30, Sweden; 6: Max Planck Institute for Biology of Ageing, Cologne, Germany; 7: Biosciences Institute, Faculty of Medical Sciences, Wellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK

Single-cell multi-omics reveals dynamics of purifying selection of pathogenic mitochondrial DNA across human immune cells

Caleb A. Lareau^1,2,3,4,5, Sonia M. Dubois⁵, Frank A. Buquicchio¹, Yu-Hsin Hsieh^6,7, Kopal Garg^4,5, Pauline Kautz^6,7,8, Lena Nitsch^6,7,9, Samantha D. Praktiknjo^6,7, Patrick Maschmeyer^6,7, Jeffrey M. Verboon^4,5, Jacob C. Gutierrez¹, Yajie Yin¹, Evgenij Fiskin⁴, Wendy Luo⁴, Eleni Mimitou^10,17, Christoph Muus^4,11, Rhea Malhotra⁴, Sumit Parikh¹², Mark D. Fleming¹³, Lena Oevermann¹⁴, Johannes Schulte¹⁴, Cornelia Eckert¹⁴, Anshul Kundaje^3,15, Peter Smibert^10,18, Ansuman T. Satpathy^1,2, Aviv Regev^4,16,19, Vijay Sankaran^4,5, Suneet Agarwal⁵, Leif S. Ludwig^4,5,6,7

1: Department of Pathology, Stanford University, Stanford, CA 94305, USA; 2: Parker Institute of Cancer Immunotherapy, San Francisco, CA 94129, USA; 3: Department of Genetics, Stanford University, Stanford, CA 94305, USA; 4: Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; 5: Division of Hematology / Oncology, Boston Children’s Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA; 6: Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; 7: Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), 10115 Berlin, Germany; 8: Institute of Biotechnology, Technische Universität Berlin, Berlin, Germany; 9: Department of Biology, Chemistry, Pharmacy, Freie Universität Berlin, Berlin, Germany; 10: Technology Innovation Lab, New York Genome Center, New York, NY 10013, USA; 11: Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02134, USA; 12: Center for Pediatric Neurosciences, Mitochondrial Medicine, Cleveland Clinic, Cleveland, OH 44195, USA; 13: Department of Pathology, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA; 14: Department of Pediatric Oncology, Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum, 13353 Berlin, Germany; 15: Department of Computer Science, Stanford University, Stanford, CA 94305, USA; 16: Department of Biology and Koch Institute, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; 17: Current address: Immunai, New York, NY 10114, USA; 18: Current address: 10x Genomics, San Francisco, CA 94111, USA; 19: Current address: Genentech, San Francisco, CA 94080, USA

Quantifying mitochondrial proteome remodeling during macrophage polarization

Joan Blanco-Fernandez, Manfredo Quadroni, Alexis A. Jourdain

University of Lausanne, Switzerland

Quantification of all 12 canonical ribonucleotides by real-time fluorogenic in vitro transcription

Janne Purhonen^1,2, Jukka Kallijarvi^1,2

1: Folkhalsan Research Center, Finland; 2: Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki

Long-read NGS for detection of mitochondrial DNA large-scale deletions and complex rearrangements

Chiara Frascarelli¹, Nadia Zanetti¹, Alessia Nasca¹, Rossella Izzo¹, Costanza Lamperti¹, Eleonora Lamantea¹, Daniele Ghezzi^1,2, Andrea Legati¹

1: Fondazione IRCCS Istituto Neurologico Carlo Besta (Milan, Italy); 2: University of Milan (Milan, Italy)

Maintenance on mitochondrial complexes ensures bioenergetic function in differentiated cells

Ilka Wittig¹, Julian Heidler¹, Heiko Giese², Ralf P. Brandes¹

1: Institute for Cardiovascular Physiology, Goethe University Frankfurt, Germany; 2: Molecular Bioinformatics, Goethe University, Frankfurt, Germany

Investigating pathogenicity and tissue-specificity of mitochondrial aminoacyl-tRNA synthetase defects AARS2, EARS2 and RARS2 in neurons

Oliver Podmanicky, Fei Gao, Denisa Hathazi, Rita Horvath

Department of Clinical Neurosciences, University of Cambridge, United Kingdom

Mutations in Coq2 leads to severe developmental delay and early death in both zebrafish and mouse

Julia Corral-Sarasa¹, Sergio López-Herrador², Juan M. Martínez-Gálvez^1,3, Pilar González-García², Laura Jiménez-Sánchez¹, Mª Elena Díaz-Casado^1,2, Luis C. López^1,2

1: Ibs.Granada, Granada, Spain; 2: Physiology Department, Biomedical Research Center, University of Granada, Granada, Spain; 3: Biofisika Institute (CSIC,UPV-EHU) and Department of Biochemistry and Molecular Biology, University of Basque Country, Leioa, Spain

Pathogenic variants of the mitochondrial metallochaperone SCO1 result in a severe, combined COX and copper deficiency that causes a dilated cardiomyopathy in the murine heart.

Sampurna Ghosh¹, Scot C. Leary¹, Paul A. Cobine²

1: University of Saskatchewan, Canada; 2: Auburn University

Tissue-specific adaptation of stress responses upon COX10 deficiency

Lea Isermann^1,2, Milica Popovic^1,2, Ming Yang^1,2, Christian Frezza^1,2, Aleksandra Trifunovic^1,2

1: CECAD Research Center, Germany; 2: Institute for Mitochondrial Diseases and Aging, Medical Faculty, University of Cologne

Using iPSC-derived neurons to unravel the pathomechanisms of Leber’s hereditary optic neuropathy

Camille Peron¹, Alessandra Maresca², Angelo Iannielli^3,4, Alberto Danese⁵, Simone Patergnani⁵, Danara Ormanbekova², Andrea Cavaliere¹, Carlotta Giorgi⁵, Paolo Pinton^5,6, Vania Broccoli^3,4, Valerio Carelli^2,7, Valeria Tiranti¹

1: Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy; 2: IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, Bologna, Italy; 3: Division of Neuroscience, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), San Raffaele Scientific Institute, via Olgettina 60, 20132, Milan, Italy; 4: National Research Council (CNR), Institute of Neuroscience, Milan, Italy; 5: Department of Medical Sciences, Laboratory for Technologies of Advanced Therapies, University of Ferrara, 44121 Ferrara, Italy; 6: Maria Cecilia Hospital, GVM Care & Research, 48033, Cotignola, Ravenna, Italy; 7: Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy

Stem cell modelling of mitochondrial disease-linked cardiomyopathy

Ann E. Frazier^1,2, Yau Chung Low^1,2, Cameron L. McKnight^1,2, Linden Muellner-Wong^1,3, Hayley L. Pointer¹, Nikeisha Caruana³, Jordan J. Crameri³, Luke E. Formosa⁴, Yilin Kang³, Thomas D. Jackson³, Alison G. Compton^1,2,5, Michael T. Ryan⁴, Andrew G. Elefanty^1,2,6, Enzo R. Porrello^1,6,7,8, David A. Stroud^1,3,5, David A. Elliott^1,2,6,7, Diana Stojanovski³, David R. Thorburn^1,2,5

1: Murdoch Children’s Research Institute, The Royal Children's Hospital, Melbourne, VIC, Australia; 2: Department of Paediatrics, The University of Melbourne, Melbourne, VIC, Australia; 3: Department of Biochemistry and Pharmacology and The Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, VIC, Australia; 4: Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia; 5: Victorian Clinical Genetics Services, The Royal Children’s Hospital, Melbourne, VIC, Australia; 6: The Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Murdoch Children's Research Institute, Melbourne, VIC, Australia; 7: Melbourne Centre for Cardiovascular Genomics and Regenerative Medicine, The Royal Children's Hospital, Melbourne, VIC, Australia; 8: Department of Anatomy and Physiology, School of Biomedical Sciences, The University of Melbourne, Melbourne, VIC, Australia

Biochemical and computational approaches to dissect the effect of MT-CYB pathogenic mutations on respiratory chain activity and assembly

Gaia Tioli, Francesco Musiani, Luisa Iommarini, Anna Maria Porcelli, Anna Maria Ghelli

Department of Pharmacy and Biotechnology, University of Bologna, Italy

Exploring the assembly and maintenance of mitochondrial complex I by complexome profiling-based approaches

Alfredo Cabrera-Orefice^1,2, Ilka Wittig¹

1: Institute for Cardiovascular Physiology, Goethe University Frankfurt, Germany; 2: Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands

Functional involvement of actin-binding Gelsolin on mitochondrial Oxphos dysfunction

María Illescas, Ana Peñas, Cristina Ugalde

Fundación Hospital 12 de Octubre, Spain

In vivo role of respiratory complex I NDUFA10 subunit in dNTP homeostasis

Andrea Férriz Gordillo¹, David Molina-Granada^1,2, Javier Ramón^1,2, Izaskun Izagirre-Urizar¹, Marina Singla-Manau¹, Maria Jesús Melià^1,2, Antoni Ruiz-Vicaria¹, Javier Torres-Torronteras^1,2, Mònica Zamora³, Michael T. Ryan⁴, Cristina Ugalde^2,5, Josep Antoni Villena⁶, Ramon Martí^1,2, Yolanda Cámara^1,2

1: Research Group on Neuromuscular and Mitochondrial Disorders, Vall d’Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain; 2: Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain; 3: BCNatal | Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), University of Barcelona, Barcelona 08028, Spain. and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona 08036, Spain.; 4: Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Australia; 5: Instituto de Investigación, Hospital Universitario 12 de Octubre, Avda. de Córdoba s/n, 28041 Madrid, Spain.; 6: Laboratory of Metabolism and Obesity, Vall d'Hebron - Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain; CIBERDEM, CIBER on Diabetes and Associated Metabolic Diseases, Instituto de Salud Carlos III, Barcelona, Spain

Modeling POLRMT pathogenic variants in the mouse

David Alsina^1,2, Roberta Filograna^1,2, Rodolfo García-Villegas^1,2, Camilla Koolmeister^1,2, Nils-Göran Larsson^1,2,3

1: Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden; 2: Max Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, Stockholm, Sweden; 3: Centre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden

The role of the CCR4 family member ANGEL1 in the expression of mitochondrial-targeted proteins

Kai Chang¹, Paula Clemente¹, Joyce Noble¹, Björn Reinius¹, Anna Wedell^1,2, Christoph Freyer^1,2, Anna Wredenberg^1,2

1: Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden; 2: Centre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden

Tissue-specific bioenergetics in mouse models of mitochondrial disease

Valeria Balmaceda¹, Timea Komoldi², Massimo Zeviani¹, Erich Gnaiger³, Anthony L. Moore⁴, Erika Fernandez Vizarra¹, Carlo Viscomi¹

1: Università di Padova; 2: Semmelweis University; 3: Universität Innsbruck; 4: University of Sussex

Yeast as a tool to investigate variants in mtARS genes associated with mitochondrial diseases

Sonia Figuccia¹, Camilla Ceccatelli Berti¹, Andrea Legati², Rossella Izzo², Alessia Nasca², Daniele Ghezzi^2,3, Paola Goffrini¹

1: Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy; 2: Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; 3: Department of Medical Physiopathology and Transplantation, University of Milan, Milan, Italy

A mutation in mouse mt-Atp6 gene induces respiration defects and opposed effects on the cell tumorigenic phenotype

Raquel Moreno-Loshuertos¹, Nieves Movilla¹, Joaquín Marco-Brualla², Ruth Soler-Agesta¹, Patricia Ferreira¹, José Antonio Enríquez³, Patricio Fernández-Silva¹

1: University of Zaragoza, Spain; 2: University of Zaragoza, Peaches Biotech Group, Spain; 3: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Spain

A systemic Muscle-WAT crosstalk progressively depletes protein and fat stores aggravating mitochondrial myopathy.

Nneka Southwell¹, Guido Primiano³, Emelie Beattie¹, Nicola Rizzardi¹, Serenella Servidei³, Giovanni Manfredi¹, Qiuying Chen², Marilena D'Aurelio¹

1: Weill Cornell Medicine, Brain and Mind Research Institute, New York, NY; 2: Weill Cornell Medicine, Department of Pharmacology, New York, NY; 3: Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy; Dipartimento di Neuroscienze, Università Cattolica del Sacro Cuore, Rome, Italy.

A novel mitochondrial assembly factor RTN4IP1 has an essential role in the final stages of Complex I assembly

Monika Oláhová^1,2, Jack J. Collier^1,3, Rachel M. Guerra⁴, Juliana Heidler⁵, Kyle Thompson¹, Robert N. Lightowlers¹, Zofia M.A. Chrzanowska-Lightowlers¹, Ilka Wittig⁵, David J. Pagliarini⁴, Robert W. Taylor¹

1: Wellcome Centre for Mitochondrial Research, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK; 2: Department of Applied Sciences, Faculty of Health & Life Sciences, Northumbria University, Newcastle upon Tyne, UK; 3: Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada; 4: Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110, USA; 5: Functional Proteomics Group, Institute for Cardiovascular Physiology, Goethe University Frankfurt, 60590, Frankfurt am Main, Germany

ETFDH supports OXPHOS efficiency in skeletal muscle by regulating coenzyme Q homeostasis

Beñat Salegi Ansa¹, Juan Cruz Herrero Martín¹, José M. Cuezva^1,2,3,4, Laura Formentini^1,2,3,4

1: Department of Molecular Biology, Centro de Biología Molecular "Severo Ochoa" (CBMSO-UAM-CSIC), Madrid, Spain; 2: Instituto Universitario de Biología Molecular (IUBM), Autonomous University of Madrid, Madrid, Spain; 3: Centro de Investigación Biomédica en red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain; 4: Instituto de Investigación Hospital 12 de octubre, i+12, Universidad Autónoma de Madrid, Madrid, Spain

Metabolic rewiring as an adaptive mechanism in COX null cells

Guillermo Puertas-Frias^1,2, Kristýna Čunátová^1,2, Petr Pecina¹, Marek Vrbacký¹, Lukáš Alán¹, Tomáš Čajka³, Josef Houštěk¹, Tomáš Mráček¹, Alena Pecinová¹

1: Department of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic; 2: Faculty of Science, Charles University, 12800 Prague, Czech Republic; 3: Laboratory of Translational Metabolomics, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic

Metabolic rewiring due to progressive increase in mtDNA mutation heteroplasmy reveals markers of disease severity

Karin Terburgh¹, Marianne Venter¹, Jeremie Z Lindeque¹, Emi Ogasawara², Mirian C H Janssen³, Jan A M Smeitink³, Kazuto Nakada⁴, Roan Louw¹

1: North-West University, South Africa; 2: Osaka University, Japan; 3: Radboud University Medical Center, Netherlands; 4: University of Tsukuba, Japan

Novel or rare AIFM1 pathogenic variants: their impact on mitochondrial metabolism and clinical manifestation in eight patients, including 3 girls

Tereza Rakosnikova¹, Jan Kulhanek¹, Martin Reboun¹, Hana Stufkova¹, Lenka Dvorakova¹, Dagmar Grecmalova², Pavlina Plevova², Tomas Honzik¹, Hana Hansikova¹, Jiri Zeman¹, Marketa Tesarova¹

1: Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague; 2: Institute of Molecular and Clinical Pathology and Medical Genetics, University Hospital Ostrava

Pathological molecular mechanisms underlying COA8 loss of function

Kristyna Cunatova^1,2, Michele Brischigliaro^1,2, Alfredo Cabrera-Orefice³, Cinzia Franchin¹, Jimin Pei⁴, Marco Roverso⁵, Sara Bogialli⁵, Qian Cong⁴, Giorgio Arrigoni¹, Susanne Arnold^3,6, Carlo Viscomi^1,2, Massimo Zeviani^2,7, Erika Fernández-Vizarra^1,2

1: Department of Biomedical Sciences, University of Padova, Padova, Italy; 2: Veneto Institute of Molecular Medicine, Padova, Italy; 3: Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands; 4: University of Texas Southwestern Medical Center, Dallas, TX, USA; 5: Department of Chemical Sciences, University of Padova, Padova, Italy; 6: Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany; 7: Department of Neurosciences, University of Padova, Padova, Italy

Retinal pathophysiology characterisation of the novel mitochondrial heteroplasmy mouse model

Lucia Luengo-Gutierrez¹, Keira Turner¹, James B Stewart², Patrick Yu-Wai-Man¹, Michal Minczuk¹

1: University of Cambridge, United Kingdom; 2: Newcastle University, United Kingdom

Impaired spermatogenesis driven by mitochondrial dysfunction and ferroptosis in primary spermatocytes in a mouse model of Leigh syndrome

Enrico Radaelli¹, Charles-Antoine Assenmacher¹, Esha Banerjee¹, Florence Manero², Salim Khiati³, Anais Girona³, Guillermo Lopez-Lluch⁴, Placido Navas⁴, Marco Spinazzi^3,5

1: University of Pennsylvania,USA; 2: University of Angers, SFR ICAT, SCIAM, 49000 Angers, France; 3: MITOLAB, University of Angers, INSERM U1083, France; 4: Pablo de Olavide University, Spain; 5: Neuromuscular Reference Center CHU Angers, France

Mitophagy dysfunction in mitochondrial myopathy and therapy by mitophagy activator CAP1902

Takayuki Mito¹, Amy E. Vincent², Julie Faitg², Kathleen Rodgers³, Kevin Gaffney³, Thomas G. McWilliams¹, Orian Shirihai⁴, Anu Suomalainen¹

1: STEMM Research Program, Biomedicum Helsinki, Faculty of Medicine, University of Helsinki, Helsinki, Finland; 2: Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK; 3: Department of Pharmacology, Center for Innovations in Brain Science, University of Arizona, Tucson, AZ, USA; 4: Department of Medicine, Endocrinology, and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

Mtfp1 controls oxidative phosphorylation and cell death in liver disease

Cecilia Patitucci¹, Juan Diego Hernández-Camacho¹, Elodie Vimont¹, Etienne Kornobis², Thibault Chaze³, Quentin Giai Gianetto^3,4, Mariette Matondo³, Anastasia Gazi⁵, Ivan Nemanyy⁶, Daniella Hock⁷, Erminia Donnarumma¹, Timothy Wai¹

1: Institut Pasteur, Mitochondrial Biology Group, CNRS UMR 3691, Université Paris Cité, Paris, France.; 2: Institut Pasteur, Biomics Technological Platform, Université Paris Cité, Paris, France.; 3: Institut Pasteur, Bioinformatics and Biostatistics Hub, Université Paris Cité, Paris, France.; 4: Institut Pasteur, Proteomics Core Facility, MSBio UtechS, UAR CNRS 2024, Université Paris Cité, Paris, France.; 5: Institut Pasteur Ultrastructural Bio Imaging, UTechS, Université Paris Cité, Paris, France.; 6: Platform for Metabolic Analyses, SFR Necker, INSERM US24/CNRS UMS 3633, Paris, France.; 7: Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia.

Non-canonical function of succinate dehydrogenase assembly factor 2 (SDHAF2) during OXPHOS dysfunction

Kugapreethan Roopasingam¹, Joanna Sacharz¹, Tegan Stait², Yau chung Low^2,3, Ann E. Frazier^2,3, David P. De souza⁴, David R. Thorburn^2,3,5, David A. Stroud^1,3,5

1: Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC, Australia; 2: Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, Australia; 3: Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia; 4: Metabolomics Australia, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC, Australia; 5: Victorian Clinical Genetics Services, Royal Children's Hospital, Parkville, VIC, Australia

NUAK1-dependent metabolic underpinnings of adult muscle stem cells

Ha-My Ly, Caroline Brun, Géraldine Meyer-Dihet, Julien Courchet, Rémi Mounier

Physiopathology and Genetics of Neurons and Muscles Laboratory, Institut NeuroMyoGène, Lyon, France

A novel approach to measure complex V ATP hydrolysis in frozen cell lysates and tissue homogenates

Lucia Fernandez del Rio^1,2, Cristiane Benincá^1,2, Frankie Villalobos^1,2, Cynthia Shu^1,2, Linsey Stiles^1,2,3, Marc Liesa^1,2,4,5, Ajit S. Divakaruni^2,3, Rebeca Acin-Perez^1,2, Orian S. Shirihai^1,2,3,4

1: Department of Medicine, Endocrinology, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095 USA; 2: Metabolism Theme, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA; 3: Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, 90095, USA; 4: Molecular & Cellular Integrative Physiology, University of California, Los Angeles, CA, 90095, USA.; 5: Institut de Biologia Molecular de Barcelona, IBMB-CSIC, Barcelona, Catalonia, 08028, Spain

OxPhos defects cause cell-autonomous and whole-body signs of hypermetabolism in cells and in patients with mitochondrial diseases

Gabriel Sturm¹, Karan Kalpita¹, Anna S Monzel¹, Balaji Santhanam¹, Tanja Taivassalo², Céline Bris³, Atif Towheed¹, Albert Higgins-Chen⁴, Meagan McManus⁵, Andres Cardenas⁶, Jue Lin⁷, Elissa Epel⁷, Shamima Rahman⁸, Jon Vissing⁹, Bruno Grassi¹⁰, Morgan Levine¹¹, Steve Horvath¹¹, Ronald G Haller¹², Guy Lenaers³, Douglas C Wallace⁵, Marie-Pierre St-Onge¹, Saeed Tavasoie¹, Vincent Procaccio³, Brett A Kaufman¹³, Erin L Seifert¹⁴, Michio Hirano¹, Martin Picard¹

1: Columbia University Irving Medical Center, United States of America; 2: University of Florida, United States of America; 3: Angers University, UMR CNRS 6015 - INSERM U1083, MitoVasc Institute, Angers, France; 4: Yale University, United States of America; 5: University of Pennsylvania, United States of America; 6: Stanford University, United States of America; 7: University of California San Francisco, United States of America; 8: Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; 9: University of Copenhagen, Denmark; 10: University of Udine, Italy; 11: Altos labs, United States of America; 12: University of Texas Southwestern Medical Center, United States of America; 13: University of Pittsburgh, United States of America; 14: Thomas Jefferson University, United States of America

Dysfunction of mitochondrial chaperone HSP60 triggers disruption of mitochondrial pathways activating multiple regulatory responses

Cagla Cömert¹, Paula Fernandez-Guerra¹, Kasper Kjær-Sørensen², Jakob Hansen³, Jesper Just^4,5, Jasper Carlsen¹, Lisbeth Schmidt-Laursen², Johan Palmfeldt¹, Peter Bross¹

1: Research Unit for Molecular Medicine, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; 2: Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark; 3: Department of Forensic Medicine, Aarhus University, Aarhus, Denmark; 4: Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; 5: Center of Functionally Integrative Neuroscience, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark

Generation of iPSCs derived neural progenitors and cardiomyocytes as cellular models to study the pathophysiology of Pearson Syndrome

Chiara Fasano¹, Luca Sala^2,3, Camille Peron¹, Andrea Cavaliere¹, Maria Nicol Colombo¹, Valeria Tiranti¹

1: Unit of Medical genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; 2: Istituto Auxologico Italiano IRCCS, Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Milan, Italy; 3: Department of Biotechnology and Biosciences, University of Milano - Bicocca, Milan, Italy

High aerobic exercise capacity predicts increased mitochondrial response to exercise training

Estelle Heyne¹, Susanne Zeeb¹, Luren G Koch², Steven L Britton³, Torsten Doenst¹, Michael Schwarzer¹

1: Department of Cardiothoracic Surgery, University Hospital of Friedrich-Schiller-University Jena, Germany; 2: Department of Physiology and Pharmacology, University of Toledo, Toledo, OH, United States; 3: Department of Anesthesiology, University of Michigan, Ann Arbor, MI, United States

Investigating the role of LONP1 in heart and skeletal muscle metabolism

Franziska Baumann¹, Dieu Hien Rozsivalova¹, Katharina Senft¹, Simon Geißen², Aleksandra Trifunovic³

1: Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), 50931 Cologne, Germany; 2: Department III of Internal Medicine, Heart Center, University Hospital of Cologne, 50931 Cologne, Germany; 3: Center for Molecular Medicine Cologne (CMMC), 50931 Cologne, Germany

Mitochondrial dysfunction promotes liver fibrosis through the ACOT2-MCT6-OXCT1 axis.

Xiaoshan Zhou¹, Sophie Curbo¹, Wei Wang², Xinling Li², Jingyi Yan¹, Yu Lei¹, Raoul Kuiper³, Ujjwal Noegi¹, Anna Karlsson¹

1: Karolinska Institutet, Sweden; 2: Zhengzhou University, China; 3: Norwegian Veterinary Institute, Norway

PNC2 (SLC25A36) deficiency associated with the hyperinsulinism/hyperammonemia syndrome

Francesco Massimo Lasorsa¹, Deborah Fratantonio², Maher A. Shahroor³, Vito Porcelli¹, Bassam Abu-Libdeh³, Orly Elpeleg⁴, Luigi Palmieri¹

1: Università degli Studi di Bari Aldo Moro, Italy; 2: Libera Università Mediterranea Giuseppe Degennaro, Italy; 3: Department of Pediatrics and Genetics, Al Makassed Hospital and Al-Quds University, Palestine.; 4: Department of Genetics, Hadassah, Hebrew University Medical Center, Israel

Cultured neurons with CoQ10 deficiency reveal alterations of lipid metabolism

Alba Pesini¹, Eliana Barriocanal-Casado¹, Giacomo Monzio-Compagnoni², Kleiner Giulio¹, Agustin Hidalgo-Gutierrez¹, Mohammed Bakkali³, Yashpal Singh Chhonker⁴, Saba Tadesse¹, Delfina Larrea¹, Daryl J Murry⁴, Caterina Mariotti⁵, Barbara Castellotti⁵, Luis Carlos Lopez³, Alesio Di Fonzo², Estela Area-Gomez¹, Catarina Quinzii¹

1: Department of Neurology, Columbia University Irving Medical Center, New York, NY, 10032, United States; 2: IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Dino Ferrari Center, Neuroscience Section, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; 3: Institute of Biotechnology, Biomedical Research Center (CIBM), Health Science Technological Park (PTS), University of Granada, Armilla, Granada, 18100, Spain; 4: Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, 986145 Nebraska Medical Center, Omaha, NE; 5: Unita` di Genetica delle Malattie Neurodegenerative e Metaboliche, Fondazione IRCCS Istituto Neurologico "Carlo Besta", Milan, 20126, Italy

An engineered variant of MECR reductase reveals indispensability of long-chain acyl-ACPs for mitochondrial respiration

M. Tanvir Rahman¹, M. Kristian Koski², Joanna Panecka-Hofman^3,4, Werner Schmitz⁵, Alexander J. Kastaniotis¹, Rebecca C. Wade^4,6, Rik K. Wierenga¹, J. Kalervo Hiltunen¹, Kaija J. Autio¹

1: Faculty of Biochemistry and Molecular Medicine, University of Oulu, Finland; 2: Biocenter Oulu, University of Oulu, Oulu, Finland; 3: Faculty of Physics, University of Warsaw, Warsaw, Poland; 4: Molecular and Cellular Modeling Group, Heidelberg Institute for Theoretical Studies (HITS), Heidelberg, Germany; 5: Department of Biochemistry and Molecular Biology, University of Würzburg, Würzburg, Germany; 6: Zentrum für Molekulare Biologie (ZMBH), DKFZ-ZMBH Alliance and Interdisciplinary Center for Scientific Computing (IWR), Heidelberg University, Heidelberg, Germany

Antibiotics directly affect mitochondrial respiration

Judith Sailer¹, Sabine Schmitt², Hans Zischka^1,3, Erich Gnaiger²

1: Technische Universität München, Germany; 2: Oroboros Instruments GmbH, Innsbruck, Austria; 3: Helmholtz Zentrum München, Germany

Can transmission of mitochondria over the species barrier promote climate change adaptation?

Kateryna Gaertner¹, Craig Michell², Riikka Tapanainen², Steffi Goffart², Sina Saari¹, Manu Soininmäki², Eric Dufour¹, Jaakko Pohjoismäki²

1: Tampere University, Finland; 2: University of Eastern Finland

Developing an in vitro model to study the impact of the m.3243A>G mutation in iPSC-derived myofibers

Gabriel E. Valdebenito, Anitta R. Chacko, Michael R. Duchen

University College London, United Kingdom

Discordant phenotype in fibroblast cell lines generated from the same MELAS patient

Monica Moresco¹, Valentina Concetta Tropeano¹, Valentina Del Dotto², Mariantonietta Capristo¹, Claudio Fiorini¹, Danara Ormanbekova¹, Chiara La Morgia^1,2, Maria Lucia Valentino^1,2, Valerio Carelli^1,2, Alessandra Maresca¹

1: IRCCS Istituto delle Scienze Neurologiche di Bologna, Italy; 2: Department of Biomedical and Neuromuscular Sciences (DIBINEM), University of Bologna

Generation of a novel CoQ deficient mouse model to elucidate the role of COQ4

Eliana Barriocanal Casado, Agustin Hidalgo-Gutierrez, Alba Pesini, Catarina M Quinzii

Department of Neurology, Columbia University Irving Medical Center, New York, New York, USA.

Perivascular adipose tissue remodeling impairs mitochondrial function in thermoneutral-housed rats

Amy C Keller¹, Melissa M Henckel¹, Leslie A Knaub¹, Greg B Pott¹, Georgia James², Jane E-B Reusch¹

1: University of Colorado/Rocky Mountain Regional VA Medical Center, United States of America; 2: Cornell College, United States of America

Temporal analysis of mitochondrial complexome profiling coupled to multi-omics analysis unveils implications of CIV remodelling in postnatal heart development

Milica Popovic, Aleksandra Trifunovic

University of Cologne, Germany

Mitochondrial dysfunction in immune cells leads to distinct transcriptome profile and improved immune competence in Drosophila

Yuliya Basikhina¹, Laura Vesala^1,2, Tea Tuomela¹, Emilia Siukola¹, Anssi Nurminen¹, Pedro F. Vale³, Tiina S. Salminen¹

1: Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; 2: Department of Molecular Biology, Umeå University, Umeå, Sweden; 3: Institute of Evolutionary Biology, School of Biological Sciences, University of Edinburgh, United Kingdom

Molecular mechanisms of extraocular muscle manifestation in mitochondrial myopathy

Swagat Pradhan, Takayuki Mito, Thomas McWilliams, Nahid Khan, Anu Suomalainen

STEMM, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland

Redox metabolites and transporters: Differential expression and ratios in specific Ndufs4 knockout mice organs.

Jeremie Zander Lindeque, Marthinus Theodorus Jooste, Daneël Nel, Belinda Fouché, Marianne Venter

Human Metabolomics, North-West University, South Africa

What makes folding of a mitochondrial protein dependent on the HSP60/HSP10 chaperone complex?

Peter Bross, Cagla Cömert, Paula Fernandez-Guerra, Johan Palmfeldt

Aarhus University and Aarhus University Hospital, Denmark

OXPHOS composition is altered in the FXNI151F mouse model of Friedreich Ataxia in a progressive and a tissue-specific way

Maria Pazos-Gil, Marta Medina-Carbonero, Arabela Sanz-Alcázar, Marta Portillo-Carrasquer, Fabien Delaspre, Elisa Cabiscol, Joaquim Ros, Jordi Tamarit

Dept. Ciències Mèdiques Bàsiques, Fac. Medicina, Universitat de Lleida. IRB Lleida.

Disease causing-Mfn2 mutations alter mitochondrial fusion and fission dynamics and metabolism.

Daniel Lagos^1,2, Nicolas Perez², Pamela R. de Santiago², Diego Troncoso², Benjamin Cartes-Saavedra², Rita Horvath¹, Veronica Eisner²

1: Department of Clinical Neurosciences, School of Clinical Medicine, University of Cambridge, Cambridge, UK.; 2: School of Biological Sciences, Department of Cellular and Molecular Biology, Pontificia Universidad Catolica de Chile, Santiago, Chile.

Dissecting the mitochondrial disease-associated ATAD3 gene cluster and its pathogenic variants

Linden Muellner-Wong^1,2, Ann E. Frazier^2,3, Eric Hanssen⁴, Tegan Stait^2,3,5, Alice J. Sharpe⁶, Danielle L. Rudler^7,8,9, Shuai Nie¹⁰, Luke E. Formosa⁶, Michael T. Ryan⁶, Aleksandra Filipovska^7,8,9, David R. Thorburn^2,3,5, David A. Stroud^1,2,5

1: Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria,Australia; 2: Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia; 3: Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia; 4: Ian Holmes Imaging Centre, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, Victoria, Australia; 5: Victorian Clinical Genetics Services, Royal Children's Hospital, Melbourne, Victoria, Australia; 6: Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia; 7: Harry Perkins Institute of Medical Research and The University of Western Australia Centre for Medical Research, QEII Medical Centre, Nedlands, Western Australia, Australia; 8: ARC Centre of Excellence in Synthetic Biology, QEII Medical Centre and University of Western Australia, Nedlands, Western Australia, Australia; 9: Telethon Kids Institute, Northern Entrance, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, Western Australia, Australia; 10: Mass Spectrometry and Proteomics Facility, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Victoria, Australia

Dynamics of adenine nucleotides in colorectal cancer clinical material

Sten Miller^1,2, Leenu Reinsalu^1,2, Marju Puurand¹, Natalja Timohhina¹, Kersti Tepp¹, Igor Sevchuk¹, Indrek Reile¹, Heiki Vija¹, Vahur Valvere³, Jelena Bogovskaja³, Tuuli Käämbre¹

1: National Institute of Chemical Physics and Biophysics, Estonia; 2: Tallinn University of Technology, Estonia; 3: North Estonia Medical Centre

The role of SURF1 protein in cytochrome c oxidase biogenesis

Maria Jose Saucedo Rodriguez¹, Petr Pecina¹, Kristýna Čunátová¹, Marek Vrbacký¹, Alena Pecinová¹, Roman Sobotka², Carlo Viscomi³, Massimo Zeviani⁴, Tomáš Mráček¹, Josef Houštěk¹

1: Institute of Physiology of the Czech Academy of Sciences, Czech Republic; 2: Institute of Microbiology, Czech Academy of Sciences, Trebon, Czech Republic; 3: Departement of Biomedical Sciences, University of Padova, Padova, Italy; 4: Departement of Neurosciences, University of Padova, Padova, Italy

Depicting inclusion body myositis using a patient-derived fibroblast model

Judith Cantó Santos^1,2,3, Laura Valls Roca^1,2,3, Ester Tobías^1,2,3, Francesc Josep García García^1,2,3, Mariona Guitart Mampel^1,2,3, Félix Andújar Sánchez^1,2,3, Anna Esteve Codina^4,5, Beatriz Martín Mur⁴, Mercedes Casado^3,6, Rafael Artuch^3,6, Estel Solsona Vilarrasa^7,8, José Carlos Fernández Checa^7,8, Carmen García Ruiz^7,8, Carles Rentero⁹, Carlos Enrich⁹, Pedro Juan Moreno Lozano^1,2,3, José César Milisenda^1,2,3, Francesc Cardellach^1,2,3, Josep Maria Grau Junyent^1,2,3, Glòria Garrabou^1,2,3

1: Laboratory of Inherited Metabolic Disorders and Muscle Disease, Centre de Recerca Biomèdica CELLEX - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain; 2: Department of Internal Medicine, Hospital Clinic of Barcelona, Barcelona, Spain; 3: CIBERER— Spanish Biomedical Research Centre in Rare Diseases, Madrid, Spain; 4: CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain; 5: Universitat Pompeu Fabra (UPF), Barcelona, Spain; 6: Department of Clinical Biochemistry, Institut de Recerca Sant Joan de Déu; Esplugues de Llobregat, Barcelona, Spain; 7: Department of Cell Death and Proliferation, Institute of Biomedical Research of Barcelona (IIBB-CSIC), Liver Unit-HCB-IDIBAPS, Barcelona, Spain; 8: CIBEREHD-Spanish Biomedical Research Centre in Hepatic and Digestive Diseases, Madrid, Spain; 9: Department of Biomedicine, Cell Biology Unit, CELLEX-IDIBAPS, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain

Effect of physiological cell culture media on cell viability and NRF2 activation

Anton Terasmaa, Rutt Taba, Marie Põlluaed, Tuuli Käämbre

National Institute of Chemical and Biological Physics, Estonia

Genetic and functional characterization of a new patient with COX4I1 deficiency

Frederic Tort¹, Olatz Ugarteburu¹, Gerard Muñoz-Pujol¹, María Unceta², Ainhoa García², Arantza Arza², Javier de las Heras², Antonia Ribes¹, Laura Gort¹

1: Hospital Clinic, IDIBAPS, CIBERER, Barcelona, Spain; 2: Hospital Universitario de Cruces, Spain

Application of the Escherichia coli Model System to Study the Human Polyribonucleotide Phosphorylase

Roberto Pizzoccheri, Federica Anna Falchi, Andrea Alloni, Francesca Forti, Sarah Sertic, Giulio Pavesi, Federica Briani

Università degli Studi di Milano, Italy

Phase two biotransformation is highly affected by mitochondrial disease: considerations for pharmacological therapies.

Marianne Venter, Belinda Fouché, Louis Mostert, Zander Lindeque, Rencia van der Sluis

Human Metabolomics, North-West University, South Africa

Mitochondrial phenotyping of fibroblasts from Kearns Sayre’s patients to model the disease

Laura Valls-Roca^1,2,3, Judith Cantó-Santos^1,2,3, Ester Tobías^1,2,3, Francesc Josep García-García^1,2,3, Félix Andújar-Sánchez^1,2, Laia Farré-Tarrats^1,2, Cristina Núñez de Arenas^3,6, Rocío Garrido-Moraga⁵, Joan Padrosa^1,2, Raquel Aránega^1,2, Pedro J. Moreno-Lozano^1,2,3, José César Milisenda^1,2, Mar O’Callaghan^3,4, Teresa García-Silva^3,5, Montserrat Morales-Conejo^3,5, Rafael Artuch^3,4, Miguel Ángel Martín^3,5, José M. Cuezva^3,6, Josep M. Grau-Junyent^1,2,3, Mariona Guitart-Mampel^1,2,3, Glòria Garrabou^1,2,3

1: Laboratory of Inherited Metabolic Disorders and Muscle Disease, Centre de Recerca Biomèdica CELLEX - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine and Health Sciences - Universitat de Barcelona (UB); Barcelona, Spain.; 2: Internal Medicine Department - Hospital Clínic de Barcelona; Barcelona, Spain.; 3: CIBERER—Spanish Biomedical Research Centre in Rare Diseases; Madrid, Spain.; 4: Hospital Sant Joan de Déu (HSJdD) de Barcelona, Barcelona, Spain.; 5: Grupo de Enfermedades Mitocondriales, Instituto de Investigación Hospital 12 de Octubre (imas12). Madrid. Spain.; 6: Centro de Biología Molecular S.O., Universidad Autónoma de Madrid (UAM); Madrid, Spain.

Effect of various mutations in the GTPase and middle domain of Drp1 on the mitochondrial network, nucleoids, and peroxisomes

Nikol Volfová¹, Aleš Hnízda¹, Lukáš Alán², Robert Dobrovolný¹, Jakub Sikora¹, Jana Křížová¹, Lucie Zdražilová¹, Hana Hansíková¹, Jiří Zeman¹, Markéta Tesařová¹

1: Department of Paediatrics and Inherited Metabolic Disorders, Charles University and General University Hospital in Prague, Prague, Czech Republic; 2: Institute of Physiology, The Czech Academy of Sciences, Prague, Czech Republic

Importance of human ClpXP protease for mitochondrial function

Daniela Burska, Jana Tesarova, Jana Krizova, Nikol Volfova, Hana Hansikova, Jiri Zeman, Lukas Stiburek

First Faculty of Medicine, Charles University; and General University Hospital in Prague

Ketogenic diet mitigates the pathogenic phenotype in TMEM70 deficient animal models

Aleksandra Marković¹, Petr Pecina¹, Alena Pecinová¹, Marek Vrbacký¹, Jana Mikešová¹, Hana Nuskova¹, Kateřina Tauchmannová¹, Otto Kučera³, Zuzana Cervinkova³, Radislav Sedláček², Josef Houštěk¹, Tomáš Mráček¹

1: Institute of Physiology of the Czech Acad. Sci., Prague, Czech Republic; 2: Institute of Molecular Genetics of the Czech Acad. Sci., Prague, Czech Republic; 3: Faculty of Medicine, Charles University, Hradec Kralove, Czech Republic

Mutation in Coq5 leads to CoQ10 deficiency, developmental delay and early death in zebrafish

Sergio López-Herrador¹, Julia Corral-Sarasa², Macarena Gil¹, Yaco Morillas¹, Luis C. López^1,2, Mª. Elena Díaz-Casado^1,2

1: Physiology Department, Biomedical Research Center, University of Granada, Granada, Spain; 2: Ibs.Granada, Granada, Spain

Omega-3 supplementation effects on mitochondrial and metabolic profile in a rabbit model of intrauterine growth restriction

Félix Andújar-Sánchez^1,2,3, Mariona Guitart-Mampel^1,2,3, Míriam Illa^3,4, Ester Tobías^1,2,3, Laura Valls-Roca^1,2,3, Judith Cantó-Santos^1,2,3, Laia Farré-Tarrats^1,2,3, Clara Oliva^3,5, Francesc Cardellach^1,2,3, Rafael Artuch^3,5, Fàtima Crispi^3,4, Glòria Garrabou^1,2,3, Francesc J García-García^1,2,3

1: Inherited metabolic diseases and muscular disorders Lab, Cellex - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine and Health Science - University of Barcelona (UB), 08036 Barcelona, Spain; 2: Internal Medicine Unit, Medicine Department, Hospital Clínic of Barcelona, 08036 Barcelona, Spain; 3: Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain; 4: BCNatal—Barcelona Centre for Maternal-Foetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), IDIBAPS, University of Barcelona, 08036 Barcelona, Spain; 5: Department of Clinical Biochemistry, Institut de Recerca de Sant Joan de Deu, Esplugues de Llobregat, 08036 Barcelona, Spain

Redundant and divergent roles of COQ8A and COQ8B in cell metabolism.

Agata Valentino¹, Elisa Baschiera¹, Iolanda Spera², Luna Laera², Valentina Giorgio³, Alessandra Castegna², Leonardo Salviati¹, Maria Andrea Desbats¹

1: Clinical Genetics Unit, Department of Women and Children’s Health, University of Padova and “Fondazione Istituto di Ricerca Pediatrica Città Della Speranza”, 35127 Padova, Italy.; 2: Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari Aldo Moro, 70121 Bari, Italy; 3: Department of Biomedical and Neuromotor Sciences, University of Bologna, I-40126 Bologna, Italy.

Loss of CHCHD8 (COA4) caused mitochondrial respiratory Complex IV deficiency

Taku Amo, Yuga Hikage

National Defense Academy, Japan

Delving into the phenotypic heterogeneity of Coenzyme Q biosynthesis defects

Ariadna Crespo-González¹, María del Mar Blanquer-Rosselló^1,2, Laura García-Corzo^1,2, Carmine Staiano^1,2, María Chacón¹, Ana Belén Cortés-Rodríguez³, Estefanía Sanabria-Reinoso¹, María Almuedo-Castillo¹, Miguel Ángel Moreno-Mateos^1,2, Gloria Brea-Calvo^1,2

1: Centro Andaluz de Biología del Desarrollo/Universidad Pablo de Olavide-CSIC-JA, Seville, Spain; 2: CIBERER, Instituto de Salud Carlos III, Madrid, Spain; 3: Laboratorio de Fisiopatología Celular y Bioenergética, Seville, Spain.

Investigating the impact of mtDNA point mutations on mitochondrial function and bioenergetics using patient fibroblasts and hiPSC derived neuronal models

Anitta Rose Chacko, Gabriel Esteban Valdebenito, Michael R Duchen

University College London, United Kingdom

Human COQ10A and COQ10B genes are essential for Coenzyme Q function in mitochondrial respiration

Elisa Baschiera¹, Carlo Viscomi¹, Maria Andrea Desbats², Placido Navas³, Leonardo Salviati^1,2

1: University of Padova, Italy; 2: Isituto di Ricerca Pediatrica - Cittá della Speranza, Italy; 3: Pablo de Olavide University, Sevilla, Spain

The use of β-RA in leptin-deficient mice reveals novel mechanisms of this compound for the treatment of obesity

Sara Torres-Rusillo¹, Sergio López-Herrador¹, Pilar González-García¹, Mª. Elena Díaz-Casado^1,2, Laura Jiménez-Sánchez², Julia Corral-Sarasa², Julio Ruiz-Travé¹, Luis C. López^1,2

1: Physiology Department, Biomedical Research Center, University of Granada, Granada, Spain; 2: Ibs.Granada, Granada, Spain

Oocyte-specific mitofusin 2 knockout enhances the metabolic disfunction of offspring born to obese mothers

Jaiane Santana da Paz, Angélica Camargo dos Santos, Lindomar Oliveira Alves, Julio Cesar Valerio Roncato, Renan Omete Ferreira, Victória Hass Gonçalves, Mirela Souza Cáceres, Marcos Roberto Chiaratti

Federal University of Sao Carlos, Brazil

Off-target effects of etomoxir: inhibition of mitochondrial Complex I and fatty acid oxidation

Timea Komlódi^1,2, Filomena SG Silva³, Ana I Duarte^3,4,5, Débora Mena^3,5,6, Luiz F Garcia-Souza¹, Marina Makrecka-Kuka⁷, Guida Bento³, Luís F Grilo^3,5,6, Paulo J Oliveira³, Erich Gnaiger¹

1: Oroboros Instruments, Innsbruck, Austria; 2: Dept Biochem, Semmelweis Univ, Budapest, Hungary; 3: CNC-Center Neurosci and Cell Biol, Univ Coimbra, Portugal; 4: IIUC-Inst Interdisciplinary Research, Univ Coimbra, Portugal; 5: CIBB-Center for Innovative Biomed Biotechnol, Univ Coimbra, Portugal; 6: PDBEB-PhD Programme in Exp Biol Biomed, IIUC, Univ Coimbra, Portugal; 7: Lab Pharmaceut Pharmacol, Latvian Inst Organic Synthesis, Riga, Latvia

Mitochondrial alterations in sirtuin1 heterozygous mice fed high fat diet and melatonin

Alessandra Stacchiotti^1,2, Francesca Arnaboldi¹, Gaia Favero³, Aleksandra Korac⁴, Maria Monsalve⁵, Rita Rezzani³

1: Dept Biomedical Sciences for Health, University of Milan, Milan, Italy; 2: Laboratorio Morfologia Umana Applicata, IRCCS Policlinico San Donato, Milan, Italy; 3: Dept Clinical and Experimental Sciences, University of Brescia, Brescia, Italy; 4: Center for Electron Microscopy, University of Belgrade, Belgrade, Serbia; 5: Instituto de Investigaciones Biomedicas “Alberto Sols” (CSIC-UAM), Madrid, Spain

Microproteins in metabolic regulation

Jiemin Nah¹, Baptiste Kerouanton¹, David Robinson², Kyle Dunlap³, Pooja Sridnivasan¹, Sonia Chothani¹, Greg Ducker³, Owen Rackham⁴, David Stroud², Lena Ho¹

1: Duke-NUS Medical School, Singapore; 2: University of Melbourne, Australia; 3: University of Utah, USA; 4: University of Southampton, UK

Oxphos deficiency indicates novel functions for the mitochondrial protein import subunit tim50

Jordan J Crameri¹, Catherine S Palmer¹, David Coman², David A Stroud¹, David R Thorburn^3,4,5, Ann E Frazier^3,4, Diana Stojanovski¹

1: Department of Biochemistry and Pharmacology and the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, 3010, Australia; 2: Queensland Children’s Hospital, Department of Metabolic Medicine, South Brisbane, Brisbane, Queensland, 4001, Australia; 3: Murdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne, Victoria, 3052, Australia; 4: Department of Paediatrics, University of Melbourne, Melbourne, Victoria, 3052, Australia; 5: Victorian Clinical Genetics Services, Royal Children’s Hospital, Melbourne, Victoria, 3052, Australia

The levels and activation state of the pyruvate dehydrogenase complex modulate the SCAFI-dependent organization of the mitochondrial respiratory chain

Sandra Lopez-Calcerrada¹, Ana Sierra-Magro¹, Erika Fernández-Vizarra², Cristina Ugalde^1,3

1: Instituto de Investigación Hospital 12 de Octubre, Madrid 28041, Spain; 2: Department of Biomedical Sciences, University of Padova, 35131 Padova, Italy; 3: Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), U723, Madrid, Spain

Development of a yeast model to characterize OPA1 mutations associated with different neuromuscular disorders

Cristina Calderan¹, Marco Marchi¹, Mara Doimo¹, Maria Andrea Desbats¹, Geppo Sartori², Leonardo Salviati¹

1: Clinical Genetics Unit, Department of Women’s and Children’s Health, University of Padua, and Istituto di Ricerca Pediatrica (IRP) Città della Speranza, Padua, Italy; 2: Department of Biomedical Sciences, University of Padua, Padua, Italy

An ultra-special family with an ultra-rare condition: three children with mithochondrial complex III deficiency due to homozygous mutations in Lyrm7

Francesca Manzoni, Titia Anita Wischmeijer, Elisa Boni, Lucio Parmeggiani, Andrea Bordugo, Francesca Pellegrini

Bolzano Hospital, Italy